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ABSTRACT OF THE DISSERTATION
INVESTIGATING THE ROLE OF THE PROXIMAL CYSTEINE HYDROGEN
BONDING NETWORK AND DISTAL POCKET IN CHLOROPEROXIDASE
by
Elwood Kwong Lam
Florida International University, 2018
Miami, Florida
Professor Xiaotang Wang, Major Professor
Chloroperoxidase (CPO) is one of the most versatile heme enzymes isolated from
the marine fungus, Caldariomyces fumago. Functionally, CPO can catalyze four types of
reactions: peroxidation (peroxidase-like), dismutation (catalase-like), halogenation
(halogenase-like), and peroxygenation (P450-like). Structurally, CPO has distal and
proximal pockets that can be best described as a hybrid of classical peroxidase and P450s.
As a heme-thiolate protein, CPO contains the conserved proximal Pro28-Cys29-Pro30
stretch found in other members of the family. However, the structural and functional roles
of these proline residues remain poorly understood.
Site-directed mutagenesis was undertaken to generates three CPO mutants, P28A-,
P30A-, P28A/P30A-CPO. The replacement of the rigid proline with a more flexible alanine
residue, freed up the back bone amide for the formation of additional amide-sulfur
hydrogen bonds, allowing the investigation of the importance of these residues in CPO
catalysis. The three CPO mutants displayed dramatic differences in ligand binding affinity
and catalytic activities relative to WT-CPO. Any mutations on the proline resides within
the proximal loop eliminated the halogenation and dismutation activities but enhanced the
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epoxidation and peroxidation activities by 4-14 fold. As for the binding affinity for cyanide,
the CPO mutants displayed significantly higher dissociation constant relative to WT-CPO.
Our results revealed that Pro28 and Pro30 play important roles in maintaining the
versatility of CPO.
As a versatile enzyme, CPO has great application potential in pharmaceutical and
chemical industry due to its ability to catalyze the formation of chiral epoxides. Phe103
and Phe186 located on the distal pocket have been proposed to guard the access of
substrates to the ferryl oxygen of the heme center. The interactions of these two
phenylalanine residues restricted the size of substrates and regulates CPO’s
enantioselectivity. F186A- and F103A/F186A-CPO were generated and characterized; the
rate of peroxidation and epoxidation were significantly enhanced at the expense of
halogenation and dismutation activities. Our results demonstrated that Phe186 played a
subtler role relative to Phe103 in terms of substrate specificity and product
enantioselectivity of CPO.
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CHAPTER I
INTRODUCTION
1.1 Heme Proteins
Heme or iron-protoporphyrin IX, consists of ferrous iron coordinated to four nitrogens
of pyrrolic groups and these groups are joined by methane bridges [1, 2]. Besides being
coordinated to the four nitrogens of the porphyrin, the heme iron is usually ligated to one
or two axial ligands such as histidine, cysteine, tyrosine, methionine, and/or lysine residues
within the protein or small molecules such as oxygen, nitric oxide, carbon monoxide, or
water [1]. There are four main types of heme: heme a, heme b, heme c and heme d1,
depending on the attached side chains along the heme plane as seen in Figure 1.1. The
general functions of heme proteins can be simplified into three categories: (1) electron
transport, (2) oxygen transport and (3) catalysis of redox reactions [3]. For example,
hemoglobin is a heme b type protein and is responsible for the transporting oxygen from
the lung to tissues. Among the different four major types of heme, heme b or iron
protoporphyrin IX is the most abundant in heme proteins. Type b heme proteins can utilize
two oxidants, peroxides or molecular oxygen, to carry out their functions, separating them
into heme peroxidases and heme oxygenases. Heme oxygenase utilizes dioxygen for
oxidation/oxygenation of substrates and the most iconic example of this type of heme
enzyme is the cytochrome P450’s family. Interestingly, the process of oxidation by
dioxygen is thermodynamically favored but there is a large kinetic barrier that prevents the
progress of these reactions [4]. Therefore, the ability of heme oxygenases to harness the
oxidative power of dioxygen has been a great interest to the field of metalloprotein
catalysis. As for heme peroxidase, these enzymes catalyze oxidation/peroxidation reactions
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using peroxide instead of dioxygen. The following sections will describe the two types of
heme proteins, heme-containing oxygenase and heme peroxidases.

Heme a

Heme b

Heme c

Heme d1

Figure 1.1 The four major types of heme found in heme proteins.
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1.2 Heme-containing Oxygenase
Heme-containing oxygenase is defined by its ability to activate molecular oxygen and
catalyze oxygenation of potential substrates. The most studied heme oxygenase or
monooxygenase has to be the cytochrome P450 family as P450 enzymes exist throughout
all domains of life catalyzing important biological oxidations such as steroid and lipid
biosynthesis, xenobiotic detoxification, and drug metabolism [5-7]. Among these oxidative
reactions, P450-catalyzed hydroxylation of inert carbon-hydrogen bond has been a great
interest because this type of reaction can only be carried out by the P450-like enzymes
which are heme-thiolate proteins, as they share a cysteine residue as proximal ligand [812]. More details of heme-thiolate protein will be discussed in section 1.4.
Another example of heme-containing oxygenase is secondary amine monooxygenase
which functions in catalyzing the oxidative dealkylation of secondary amines to aldehydes
and primary amines. Structurally, secondary amine monooxygenase contains the heme
cofactor that is responsible for catalysis and also flavin mononucleotide and Fe 2S2
prosthetic groups that have been proposed to play a role in modulating the transport of
electrons from NADPH to the heme center [13]. Interestingly, the second purified
monooxygenase, secondary amine monooxygenase contains a histidine residue as the
proximal ligand unlike P450 enzymes [14]. Therefore, this leads to the question of the
structural requirement for activating molecular oxygen as this monooxygenase contains an
active site that resembles that of myoglobin.
Besides P450 enzymes and secondary amine monooxygenase, heme oxygenase (HO)
is a unique type of heme protein catalyzes the oxidation of heme b leading to the release of
carbon monoxide, Fe3+, and biliverdin. The uniqueness of this enzyme is that it does not
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actually contain heme as cofactor; rather, the free heme binds to the enzyme during
catalysis forming this transient heme protein state [4, 13]. Like P450 enzymes and
secondary amine monooxygenase, the ferric heme iron of heme oxygenase needs to be
reduced to ferrous iron before the binding of molecular oxygen to the heme iron as
demonstrated in P450’s catalytic cycle in Figure 1.2 [15]. After molecular oxygen is bound
to the heme iron, a second electron and two hydrogen protons are needed for the release of
a water molecule. The electron transferring process from NADPH to the heme iron is
regulated by the enzyme, diflavin cytochrome P450 reductase, which is used by the three
heme oxygenases described [13, 16]. The axial heme ligand HO is a histidine residue, in
analogy to secondary amine monooxygenase.

Figure 1.2 The catalytic cycle of cytochrome P450 with the redox partner being
diflavin cytrochrome P450 reductase and NADPH [17].
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1.3 Heme Peroxidases
As the heme center of HO and secondary amine monooxygenase is ligated to a histidine
residue, most heme peroxidases are also heme-imidazole ligated proteins. Heme
peroxidases use hydrogen peroxide instead of molecular oxygen as oxidizing agent to
catalyzes the one- and two-electron oxidation reactions. These reactions include the
formation of a radical from the oxidized one-electron donor molecule and two-electron
oxidation of halides ions to hypohalous acids (Figure 1.3, reaction 1 & 2). Examples of
classical heme peroxidases include horseradish peroxidase [18], cytochrome c peroxidase
[19] and lignin peroxidase [20]. There are four heme peroxidase superfamilies: peroxidasecatalase, peroxidase-cyclooxygenase, peroxidase-chlorite dismutase and peroxidaseperoxygenase superfamily [21, 22]. Each superfamily is distinguished by its distinctive
active site and enzymatic activities in addition to peroxidase activity. For example,
peroxidase-catalase can catalyze the decomposition of hydrogen peroxide to protect the
proteins from oxidative damage (Figure 1.3, reaction 3) [23]. Cytochrome c peroxidase is
a classic example of peroxidase-catalase superfamily and it was one of the first heme
peroxidase to be crystallized [24]. Thus, CcP has served as benchmark for the studies of
other peroxidases. The structure of CcP along with others heme peroxidases revealed
catalytically important conserved regions found in heme peroxidase-catalase superfamily.
For example, the heme of CcP is coordinated to a histidine (His175) ligand which forms
hydrogen bonds with nearby residues such as Asp and Trp or Phe. This proximal HisTrp/Phe-Asp triad along with the distal His-Trp/Phe-Arg triad are conserved in most
peroxidases and have been proposed to be catalytic significant [21, 25]. Exceptions include
monofunctional catalase, in which the proximal ligand is a tyrosine residue, and
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peroxidase-peroxygenase, a superfamily responsible for catalyzing the oxygen-insertion
reaction of organic molecules (Figure 1.3, reaction 4), such as chloroperoxidase and
unspecific peroxygenase that contain a cysteine proximal ligand [8]. The different proximal
ligand between heme-imidazole and heme-thiolate protein is illustrated by Figure 1.4.
(1) 2𝑅𝐻 + 𝐻2 𝑂2 → 2𝑅. + 2𝐻2 𝑂 → 𝑅 − 𝑅 + 2𝐻2 𝑂
(2) 𝑋 − + 𝐻2 𝑂2 + 𝐻 + → 𝐻𝑂𝑋 + 𝐻2 𝑂
(3) 2𝐻2 𝑂2 → 𝑂2 + 2𝐻2 𝑂
(4) 𝑅𝐻 + 𝐻2 𝑂2 → 𝑅𝑂𝐻 + 𝐻2 𝑂
Figure 1.3 Four types of reactions catalyzed by heme peroxidase. (1) Peroxidasecatalyzed peroxidation reaction. (2) Peroxidase-catalyzed halogenation reaction. (3)
Peroxidase-catalyzed dismutation reaction. (4) Peroxidase-catalyzed peroxygenation
reaction. RH represents substrates; X- is the halide ions (Cl-, Br-, or I-)

Figure 1.4 Structure of (A) Heme-imidazole and (B) Heme-thiolate proteins.
1.4 Heme-thiolate Proteins
Heme-thiolate proteins are hemoproteins with a cysteine as the proximal heme ligand
instead of a histidine as found in classical peroxidases. Upon binding of carbon monoxide,
the UV-Vis spectrum of heme-thiolate proteins exhibits a prominent Soret peak near 450
nm for this carbonmonoxy complex while heme-imidazole proteins have a Soret peak
around 420 nm [26-28]. Therefore, carbon monoxide has been used to probe the identity
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of the proximal heme ligand. The absorption peak near 450 nm is the origin of the name
P450 because cytochrome P450 is the first class of hemoprotein to display this
spectroscopic characteristic when bound to carbon monoxide. P450 can catalyze a wide
range of biological oxidative reactions and the catalytic capability of this protein has been
proposed to be modulated by the axial ligand [8, 29]. The C357H mutation eliminated the
hydroxylating activity of P450cam for camphor and reduced the rate of the reactive species
formation [10, 29]. The dramatic changes in terms of electron donating properties from
cysteine to histidine altered the proximal heme environment thus affected the catalytic
activity, as observed for C357H-P450cam. Even though heme-thiolate proteins share the
same axial cysteine ligand, their primary catalytic functions vary dramatically. For
example, P450 catalyzes monooxygenase reactions, CPO catalyzes haloperoxidase
reactions, while NOS catalyzes the production of NO through the oxidation of L-arginine
(Figure 1.5) [6, 16, 30-32].
CPO is the first haloperoxidase that was categorized into the heme-thiolate protein
family and has been known as one of the most versatile hemoprotein. The primary function
of CPO has been proposed to catalyze the chlorination reaction during the biosynthesis of
the antibiotic caldariomycin [33-36]. The spectroscopic signature of the carbonmonoxy
complex of ferrous CPO resembles that of P450 which suggested identity of the proximal
ligand between these two enzymes is the same [37]. In addition, the crystal structure of
CPO confirmed the identity of the proximal ligand is a thiolate anion from a cysteine
residue [38]. This enzyme has served as a model for studies of heme-thiolate proteins,
especially when determining the reactive intermediates in the catalytic cycle because
Compound I of P450 is highly unstable, and until recently, capturing this species has
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proven to be problematic. Therefore, Compound I of CPO as well as model-based studies
have been used to investigative the reactive species and the mechanism of P450s [39-43].
More recently, the availability of Compound I of P450 has shown that the reactive species
of the two heme-thiolate enzymes displayed similar UV/Visible and Mössbauer spectra but
differ in electron paramagnetic resonance spectrum [44].
(A)

(B)

Figure 1.5 Structures of P450cam, CPO and iNOS (A) [32] and their respective
catalyzed reactions (B).
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In recent years, the arise of another haloperoxidase that belong in the heme-thiolate
protein family is unspecific peroxygenase (UPO) [45, 46]. This type of enzyme was first
discovered in the basidiomycetous fungus, Agrocybe aegerita, known as AaP or AaeUPO.
AaP was known as an “alkaline lignin peroxidase” because this enzyme oxidizes veratryl
alcohol into its corresponding aldehyde at neutral pH [47, 48]. However, the mechanism
of the degradation of lignin catalyzed by AaP was found to be different than that of lignin
peroxidase as LiP involves the formation of an aryl cation radical while AaP forms a
geminal alcohol [49, 50]. Besides peroxidase activity, AaP can catalyze the halogenation
of monochlorodimedone and phenol in a H2O2-dependent manner that resembles CPO [31,
46]. In terms of protein sequence, there is only about 30% similarity in the N-terminal
region, which comprises the proximal region as well as part of the distal pocket between
AaP and CPO as observed in Figure 1.6 [51]. AaP shares similarity with CPO but AaP
displays higher peroxygenase activity toward aliphatic and aromatic hydrocarbons as well
as numerous organic substrates [52]. This oxygen-insertion potential of AaP resembles that
of P450s. In addition, the spectroscopic characteristics such as the resting ferric state of
AaP are similar to those of P450, which is in a low-spin state, while ferric CPO exists as a
penta-coordinated high-spin species. Therefore, AaP or UPO have been proposed to be the
missing link between CPO and P450s.
The rising interest in AaP’s peroxygenase activity altered the name of this enzyme
from haloperoxidase to aromatic peroxygenase and then to UPO as a result of its
unusual/versatile enzymatic activities [53]. The second UPO discovered is CraUPO
secreted by Coprinellus radians and it shares much similarity with AaeUPO such as
catalyzing the hydroxylation of naphthalene [45, 50]. As heme-thiolate proteins, UPOs
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catalyze oxygen-insertion into aromatic substrates with great efficiency that are not P450
enzymes, which revealed an alternate potential biocatalyst with several advantages such as
a simpler system without the need of flavin reductases [54].

Figure 1.6 Alignment of the protein sequences of AaP and CPO with high homology
regions highlighted. Dark gray represented identical residues while light gray is
residues with chemical similarity. Underlined residues are the N-glycosylation sites
[51].
1.5 Overview of CPO
Chloroperoxidase (CPO) is isolated from the marine fungus, Cardarimycin fumago by
Dr. Hager and his group in early 1960s [33, 34]. This versatile enzyme’s primary function
as a halogenase catalyzing oxidation of halides such as chloride, bromide and iodide [55,
56]. The halogenating activity of CPO have been suggested to be the possible natural
production of organochlorine compounds in the environment [57]. Besides being
haloperoxidase, CPO can also catalyze other two-election oxidation reactions such as
dismutation of hydrogen peroxide as well as peroxygenation reactions. Peroxygenation
reactions such as epoxidation of olefins have shown to produce high yield with high
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stereoselectivity. In addition, as a heme peroxidase, CPO also function as a peroxidase that
catalyzes one-electron peroxidation reactions [58]. CPO’s versatility was linked to the
“peroxidase-P450” hybrid structure of this enzyme [38]. Unraveling the structure-function
relationship of CPO have been a great interest since this heme-thiolate protein have great
potential for industrial application.
1.5.1

Structure of CPO

CPO is a heavily glycosylated extracellular enzyme which 25-30% of the molecular
weight is carbohydrate [59]. CPO’s gene encoded 372 amino acid residues and after the
proteolytic cleavage process; 21aa from the N-terminal signal peptide and 52aa from the
C-terminal propeptide were removed leaving the mature protein with 299aa residues and a
molecular weight of approximately 42,000 Da [60]. The crystal structure of CPO revealed
that the heme center was mainly surrounded by eight alpha helixes (A-H), three short
helices and a short antiparallel beta pair (Figure 1.7) [38]. The structure of CPO is unique
among peroxidases and heme-thiolate proteins, but it shares the similarity of a polar
substrate-binding pocket and axial ligand, respectively. The proximal cysteine ligand is
located in the N-terminal helix A. This helix is orientated perpendicular to the heme plane
and possess an electropositive environment that fine-tunes the electronegativity of the axial
ligand [38]. In other peroxidases and P450s, the helix containing the axial ligand is usually
orientated parallel to the heme [24, 61].
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Figure 1.7 Crystal structure of chloroperoxidase from C. fumago [38]. The manganese
is represented by the brown sphere near the heme center. PDB file of 1CPO was used
to generate this figure.
The orientation of the proximal helix is different between P450 and CPO, but they share
a similar three residue stretch around the cysteine ligand, X-Cys-X. For CPO, the stretch
is a Pro-Cys-Pro tripeptide which is superimposed to various structures of heme-thiolate
proteins. For example, in the proximal helix of CPO and AaP, they shared a similar
structural motif of Arg-Gly/Ala-Pro-Cys-Pro-Ala/Gly-Leu-Asn. This motif is found to be
conserved throughout the peroxidase-peroxygenase superfamily (Figure 1.6). Interestingly,
the crystal structure of beef liver catalase shows that the axial ligand, Tyr357, is adjacent
to the proline residue, Pro358 which been proposed to restrict the movement of the tyrosine
[62].
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The rich electron-donating properties of the proximal thiolate of CPO is modulated by
the proximal helix environment.

In heme-thiolate proteins, there is an amide-sulfur

hydrogen bonding network located in the proximal pocket that regulates the
electronegativity of the proximal ligand [8, 11, 63-69]. In CPO, the sulfur atom of Cys29
form an amide-sulfur hydrogen bonding network with nearby residues, Ala31 and Leu32
[38, 70]. This hydrogen bonding network is believed to upregulates the redox potential of
the heme iron as well as lowering the pK a of the distal ligand [41, 67]. The redox potentials
of CPO are highly pH-dependent as the redox potential is -140 mV at pH 6.90 and +150
mV at pH 2.70 [71]. The pH-dependency of the redox potential of CPO explains why this
enzyme has an optimum pH at highly acidic level for chlorination, as the high redox
potential requirement for oxidizing chloride during the reaction.
According to the crystal structure of CPO, the distal region is composed of mostly polar
residues such as Glu, Asp, and His, that resembles classical peroxidases. On the surface,
two channels, one wide and one narrow, connects the surface to the heme center (Figure
1.8). Among the two channels, halide binding sites were only found in the narrow channel.
However, halides might have diffused through the wide channel, where no binding site was
observed in the crystal structure, to the heme center [70].
At the bottom of the two channels, they formed the substrate-binding pocket allowing
the direct access to the heme. The substrate-binding pocket is formed by the hydrophobic
residues consisting of Phe103, Leu70, Phe186, Val182, and Ala267. The sidechains of
Phe103 and Phe186 are parallel to the heme plane and they are 6.2 Ǻ away from each other.
Phe103 has been shown to be flexible as the sidechain is displaced during the binding of
the substrate to the distal pocket [38, 70]. For P450, a substrate-binding pocket allows
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direct interaction between the substrate and the ferryl oxygen. However, heme peroxidases
has restricted access to the ferryl oxygen and the substrate interacts with the enzyme
through the heme edge. As for CPO, this enzyme utilizes both types of mechanisms
depending on the types of reactions [58]. In the distal region, there is an acid-base catalyst
responsible for the formation of the reactive species, Compound I. The acid-base catalyst
responsible for the deprotonation of H2O2 and the cleavage of the O-O bond is a glutamic
acid residue (Glu183) for CPO while a histidine residue commonly found to plays this role
in other peroxidases such as CcP (Figure 1.9) [72, 73]. The role histidine (His105) plays in
CPO is subtler as to other peroxidase, where His105 form a hydrogen bond with Glu183
and act as a proton shuttle during the cleavage of the peroxide bond [74].

Figure 1.8 Slice through surface representation of CPO with the two channels
connected to the active site [70]. Color representations: heme, magenta; bromide,
yellow; iodide, blue.
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Figure 1.9 The acid-base catalyst of CPO(Left) and CcP(Right) are glutamic acid and
histidine, respectively. The following PDB files were used to generate the figure:
1CPO and 2XIL
1.5.2

Catalytic Cycle of CPO

Compound I is defined as a oxo-ferryl radical species, where the radical can be located
on either the porphyrin (such as HRP and CPO) or nearby residue (such as CcP), and is
found throughout the catalytic cycle of heme enzymes. In term of CPO, the catalytic cycle
began as a high-spin ferric state or resting state. The addition of hydrogen peroxide,
oxidized the heme iron which results in the formation of Compound I, an oxo-ferryl
porphyrin cation-radical. As shown in Figure 1.10, hydrogen peroxide binds to the ferric
heme iron then the distal Glu183 deprotonates the proximal hydrogen of the peroxide
forming the transient intermediate, Fe(III)-OOH, known as Compound 0. The protonated
Glu183 will then protonates the distal oxygen of the peroxide as well as breaking the O-O
bond leading to the release of water and the formation of Compound I [75, 76].
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Figure 1.10 Proposed Mechanistic Formation of Compound 0, I, II, and III of CPO
[77].
As one of the most versatile heme enzyme, Compound I of CPO can participate in
different pathways catalyzing different reactions. As suggested by Dr. Hager, CPO-I can
go through any of the four pathways which result in the return to its resting state (Figure
1.11). As peroxidase, CPO-I catalyzes two one-electron oxidations of organic molecules
to a radical cation. After catalyzing the first one-electron oxidation, CPO-I is reduced to a
second intermediate known as Compound II. Compound II of CPO or CPO-II is an oxoferryl species with one oxidation equivalent lower than CPO-I. X-ray absorption
spectroscopic study on CPO-II by Dr. Green and his group revealed that the bond length
of the Fe-O bond is 1.82 Ǻ, which suggests the presence of a single bond instead of a
double bond [78]. Therefore, CPO-II exists mainly in a protonated ferryl form with minor
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species as an unprotonated ferryl form. The second one-electron oxidation reaction returns
CPO back to its resting state. However, CPO-II can react with the excess hydrogen
peroxide generating the third intermediate known as Compound III (Figure 1.10). This
intermediate is interconnected with the H2O2-dependent deactivation process of heme
peroxidase as well as the possible involvement with the chlorination reaction catalyzed by
CPO [72]. CPO-catalyzed peroxidation reaction has been proposed to occur predominantly
outside of the heme active site as the substrate bind to the surface of the enzyme and
mediated the electrons transfer through the heme edge (Figure 1.12, route b).
In halogenation reaction, halide ions were diffused into the active site through the
narrow channel as there are multiple binding sites presented [70]. The halide ion reacts
with CPO-I to form the ferric Fe-OCl- intermediate, Compound X (Figure 1.12, route a)
[79] CPO-catalyzed chlorination is highly pH-dependent as the optimal pH is around 2.75,
and when the pH increases, the activity decreases dramatically. The reason for such a low
pH optimum was explained in a study which demonstrated the chlorination of
monochlorodimedone (MCD) to dichlorodimedone (DCD) was catalyzed by the
protonated form of Fe-HOCl instead of the unprotonated ferric Fe-OCl-. The mechanism
of the halogenation reaction catalyzed by CPO is still in controversial as whether the
chlorination occurs within the heme active site or through a diffusible species. However,
a proposed mechanism for chlorination of MCD is shown in Figure 1.13 [80].
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Figure 1.11 Catalytic cycle of CPO as suggested by Dr. Hager. R or RH represented
organic substrate while X- represented a halide ion besides fluoride.

Figure 1.12 The simplified mechanistic route for CPO-catalyzed halogenation (a),
peroxidation (b) and peroxygenation (c) reactions [81]. R or RH represented organic
substrate while X- represented a halide ion besides fluoride.

18

Figure 1.13 The proposed mechanism for chlorination of MCD catalyzed by CPO
[80].
As a heme-thiolate protein, CPO catalyzed peroxygenation/oxygen-insertion reactions
as a two-electron oxidation process similar to P450 enzymes. This type of reaction occurs
within the active site of CPO (Figure 1.12, route c), as the reaction was hindered when all
the histidine residues in the active site were alkylated [58]. The intermediate involved in
CPO’s catalysis is still unclear; however, the reaction might proceed through a dual
oxygen-transfer mechanism that involve two different electrophilic species, oxoferryl
species and iron hydroperoxide species, as illustrated in Figure 1.14 [82].

19

Figure 1.14 The proposed mechanism for oxygen-insertion reaction via a dual
mechanism: (a) an oxoferryl species that inserts oxygen and (b) an iron
hydroperoxide species that inserts OH+ (Modified figure from van Rantwijk et al.)
[82].
Another type of two-electron oxidation reaction catalyzed by CPO is the dismutation
of hydrogen peroxide. In this route, CPO-I catalyzes the decomposition of a second
molecule of hydrogen peroxide into dioxygen and water. On the basis of the Compound X
involvement in halogenation pathway, the proposed mechanism of the catalase pathway
might involve the formation of this CPO-I-H2O2 complex as illustrated in Figure 1.15 [83].
An acid-base catalyst, in the case of CPO, Glu183 will deprotonate the proximal oxygen
and then protonate the distal oxygen of the peroxide, leading to the release molecular
oxygen and water. However, this proposed mechanism seems to go through a two oneelectron transfer process instead of commonly assumed two-electron oxidation process
[84]. Therefore, the exact mechanism of the catalase pathway of CPO is still unclear.
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Figure 1.15 Proposed mechanism for dismutation of hydrogen peroxide catalyzed by
CPO (Modified figure from Dr. Cécile Claude) [85]
1.5.3

Significant of CPO-catalyzed reactions

1.5.3.1 Halogneation Reactions
As previously stated, CPO is one of the most versatile heme enzyme capable of
catalyzing different one-electron or two-electron oxidation reactions through different
catalytic pathways. Possible substrates for CPO-catalyzed halogenation include alkenes
[86-88], alkynes [89], anisole [90], β-diketones [33, 91], β-keto acid [55], phenols [92],
and aromatic hydrocarbons [93]. Examples of halogenation reactions are shown in Figure
1.16. Many studies have suggested that CPO or CPO-like enzymes are responsible for the
natural production of organochlorine compounds found in the environment. CPO have
been demonstrated to mediates the chlorination of polycylic aromatic hydrocarbons with 5
and 6 aromatic rings, and the aromatic groups in fulvic acid as well as the bromination of
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flavanones [57, 93-95]. Aromatic hydrocarbon pollutants can cause more severe damage
as they can form these high molecular-weight halogenated compounds which are highly
toxic to the environment and the formation of these compounds need to be fully understood
to better protect the environment.

Figure 1.16 Halogenation reactions catalyzed by CPO: (A) alkene, (B) alkynes, (C)
anisole, (D) phenol, (E) monochlorodimedone, (F) anthracene (aromatic
hydrocarbon).
1.5.3.2 Peroxidation Reactions
Although CPO primary acts as a haloperoxidase, this enzyme can also catalyze
oxidative dehalogenation of halophenols to less hazardous products, which implicates its
possible application in bioremediation [96, 97]. Like other peroxidases, CPO can catalyze
peroxidation reactions through two one-electron transfer processes. In the case of monohalophenols, 4-chlorophenol and 4-fluorophenol were significantly degraded by CPO,
leading to the formation of quinones and biphenyl-like compounds [30, 98, 99]. Similar
result was observed for pentachlorophenol, as CPO mediated the transformation of this
substrate into a polymeric and insoluble material that is more readily remove from the
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environment [100]. The formation of dimers, trimers, and polymers have been proposed to
be involved by the initial formation of phenolic radicals catalyzed by CPO involving the
peroxidase’s nature of this enzyme. An example is shown in Figure 1.17 [99]. This was
confirmed by Osborne et al. in which the rapid scan stopped-flow spectroscopic spectral
on the reactions of CPO-I and CPO-II with 2,4,6-trichlorophenol clearly revealed that the
oxidative dehalogenation of TCP to 2,6-dichloro-1,4-bezoquinone occured through a two
steps process. The proposed reaction scheme for oxidative dehalogenation of TCP
catalyzed by CPO is shown in Figure 1.18 [96, 97]. Interestingly, CPO is the only
peroxidase that can catalyze halogenation and dehalogenation reactions with significantly
higher dehalogenating activity than other peroxidases such as lignin peroxidase and HRP
[101].
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Figure 1.17 Initial formation of phenolic radical from the oxidation of fluorophenol
catalyzed by CPO and the possible products yielded [99].
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Figure 1.18 Two steps one-electron oxidative dehalogenation catalyzed by CPO
involving CPO-I and CPO-II [97].
1.5.3.3 Oxygen-insertion Reactions
As stated in earlier section, CPO can catalyze P450-like or oxygen-insertion reactions.
These reactions go through the regio- and enantioselective peroxygenation of the substrate,
resulting the formation of prochiral or chiral products [30, 31]. For example, CPO catalyzes
sulfoxidation of sulfides such as alkyl aryl sulfides and β-carbonyl sulfides, to their
corresponded sulfoxides with great yield as well as high enantiomeric excess, favoring the
(R)-configuration as shown in Figure 1.19 [102-104]. In terms of bioremediation,
organosulfides and thiophenes in diesel fuel can be oxidized by CPO yielding (R)sulfoxides and sulfone that can be effectively remove through distillation [105]. The
stereoselective manner of CPO-catalyzed peroxygenation reactions has been a great
interest to the pharmaceutical industry as enantiopure sulfoxides are important chiral
synthons for asymmetric synthesis of natural products and biologically active compounds
[106]. For example, CPO has demonstrated to synthesize (R)-modafinil through the
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enantioselective sulfoxidation of 2-(diphenylmethylthio) acetamide in an one step process
with yield of 40.8% and the ee value of 97.3% [107].

Figure 1.19 CPO-catalyzed sulfoxidation of various sulfides with their corresponded
sulfoxides yield and enantiomeric excess percentage [102, 103].
Another type of reaction catalyzed by CPO that has been a great interest in the field of
pharmaceutical and synthetic chemical industries is the epoxidation reaction. Many studies
revealed that CPO catalyzes epoxidation of cis-disubstituted, 1,1-disubstituded, and
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trisubstituted alkenes with less than 8 carbons with great yield and ee. However, transolefins, and terminal and mono-substituted alkenes are poor substrates for CPO. Majority
of CPO-catalyzed epoxidation reactions yielded in (R)-configuration epoxides as shown in
Figure 1.20 [108-110]. These chiral epoxides have served as drug intermediates and the
enzymatic synthesis of these compounds have shown to be more environmental friendly
and cost-efficient relative to the organic synthesis methods. Practical examples such as
CPO-assisted synthesis of (R)-(-)-mevalonolactone and (R)-dimethyl 2-methylaziridine1,2-dicarboxylate showed great efficiency [111, 112]. The disadvantage of CPO is the
presence of the catalatic activity, depleting the amount of oxidant such as hydrogen
peroxide for the formation of Compound I. The replacement of the hydrogen peroxide with
tert-butyl peroxide as oxidant was shown to have a better yield and enhanced the turnover
number for the CPO [113, 114].
(A)

100%, ee 95%

(B)

20%, ee 95%

(C)
2%, ee 0%

(D)

40%, ee 49%

Figure 1.20 CPO-catalyzed epoxidation of various (A-C) olefins and (D) styrene to
their corresponded epoxides yield and enantiomeric excess percentage [108].

27

Epoxidation and sulfoxidation both occur in a stereoselective manner with favoring of
the (R)-configuration. However, hydroxylation is a type of oxygen-insertion reactions that
can be stereoselective or nonstereoselective depending on the nature of the substrate. For
example, CPO-catalyzed oxidation of 1,3-cyclohexadienes and 1,3-cyclohexadiene
diacetate resulted in a product with an ee of 78% and a racemic mixture, respectively.
Possible substrates for CPO-catalyzed hydroxylation are acetylenes [115], cyclic
conjugated dienes[116, 117], p-methyl and p-ethyl anisole as well as others benzylic
compounds [108, 118], and monoterpenes [119] and examples are shown in Figure 1.21.
Interestingly, CPO can hydroxylate ethylbenzene and propylbenzene to (R)-2-phenethyl
alcohol and (S)-1-phenyl-1-propanol, respectively [108]. Even though they yielded
different configurations, both reactions yielded a high ee value of greater than 88%.
Another factor that contribute to the stereoselectivity of the hydroxylation reactions is the
condition of the reaction system. As observed for the oxidation of R-(+)-limonene, the
presence of KCl and absence of KCl yielded in different degree of stereoselectivity as
observed in Figure 1.21 (D) [119]. In the bracket of C and D in Figure 1.21, the proposed
epoxide intermediates were spontaneously hydrolyzed to form the hydroxylated products.
In addition, further oxidation of alcohols to aldehydes were observed for CPO-catalyzed
hydroxylation reactions [120, 121]. For example, CPO can catalyze the oxidation of amino
alcohol during the synthesis of N-Cbz-3-aminopropanal [122]. The versatility of CPO
illustrated the potential of this biocatalyst for practical applications; however, the
mechanisms for these reactions are still in controversial. Therefore, the study on the
structure-function relationship of CPO is essential for practical application of this
biocatalyst and would further our understanding on heme-thiolate proteins.
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(A)
26%, ee 91%

(B)

20%, ee 97%

(C)

50 and 34% ee 70%

(D)

Figure 1.21 CPO-catalyzed progargylic hydroxidation (A), benzylic hydroxylation
(B), cyclic conjugated diene hydroxylation (C) and R-(+)-limonene hydroxylation in
the presence and absence of KCl [108, 115-118].
1.5.4

Mutagenesis Approaches on CPO

To investigate the structure-function relationship of CPO, many site-directed
mutagenesis studies were previously performed. The studies focused on the distal pocket
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of CPO are summarized in Table 1.1. Most of the distal CPO mutants shared similar
catalytic activities as the chlorination and dismutation activities were diminished while the
epoxidation and peroxidation activities were enhanced. Similar activity changes for the
distal CPO mutants were observed for the proximal CPO mutants as listed in Table 1.2.
My research investigated the effects of the proximal helix as well as the distal substratebinding pocket on the structural and biochemical properties of CPO. In addition, we
investigated the importance of the distal pocket on modulating the enantioselectivity of
styrene derivative substrates.
Table 1.1 The effects of the distal environment of CPO on its catalytic activities.
Distal CPO Mutants
N74V
N74Q

Activity
References
Increased in epoxidation activity, decreased [123]
in chlorination and dismutation activities

F103A

No sign of chlorination and dismutation [124]
activities, increased in epoxidation and
peroxidation activities

H105A

Increased in epoxidation activity, decreased [123]
in chlorination and dismutation activity

E183H

Increased in epoxidation activity, decreased [125]
in chlorination and dismutation activities

F186A

No sign of chlorination activity, decreased This work
in dismutation activities, and increased in
epoxidation and peroxidation activities

F103A/F186A

No sign of chlorination activity, decreased This work
in dismutation activities, and increased in
epoxidation and peroxidation activities
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Table 1.2 The effects of the proximal helix of CPO on its catalytic activities.
Proximal CPO Mutant
R26A

Activity
References
No sign of chlorination activity, decreased [126]
in dismutation activity, increased in
epoxidation activity

P28A

No sign of chlorination and dismutation This work
activities, increased in epoxidation and
peroxidation activities

C29H

Retained similar catalytic activities as WT- [127]
CPO
No sign of chlorination and dismutation [126]
activities, increased in epoxidation and
peroxidation activities

C29H/C79H/C87H

Increased
in epoxidation activity, [126]
decreased in chlorination and dismutation
activities

P30A

No sign of chlorination activity, decreased This work
in dismutation activities, and increased in
epoxidation and peroxidation activities

P28A/P30A

No sign of chlorination and dismutation This work
activities, increased in epoxidation and
peroxidation activities

N33A

No sign of chlorination and dismutation [126]
activities, increased in epoxidation and
peroxidation activities

R26A/N33A

No sign of chlorination and dismutation [126]
activities, increased in epoxidation and
peroxidation activities
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CHAPTER II.
INFLUENCE OF THE PRO-CYS-PRO TRIPEPTIDE IN THE PROXIMAL
LOOP ON THE SPECTROSCOPIC PROPERTIES OF CHLOROPEROXIDASE
2.1 Background
The active site of CPO can be divided into the distal and proximal regions by the heme
center. As stated in the previous chapter, the distal pocket of CPO contains residues that
interact with the substrate, regulating the stereoselectivity of the reaction. The catalytic
heme center is covalently bound to the proximal ligand, cysteine, which is located on the
beginning of helix A. Within the proximal pocket of CPO, there is a hydrogen bonding
network form between helix A and the nearby loop, Arg26-Asn37 and Ala27-Asn33, as
observed in Figure 2.1. This hydrogen bonding network is previously studied in our
research lab and shown to play an important role in maintaining the secondary and tertiary
structure of CPO as well as other spectroscopic properties of the enzyme [126]. In CPO,
another type of hydrogen bonding network is also found in the proximal region, which is
the amide-sulfur hydrogen bonding network. This type of hydrogen bonding network is
conserved throughout heme-thiolate proteins as observed in P450 enzymes, NOS and
APOs [31, 53, 80]. In P450cam, the proximal region contains three amide-sulfur hydrogen
bonds between the axial ligand, Cys357, and the adjacent residues, Leu358, Gly359, and
Gln360. As for CPO, the sulfur atom of Cys29 form two amide-sulfur hydrogen bonds with
the backbone amide of Ala31 and Leu32. In CPO, Cys29 residue is sandwiched by two
proline residues, Pro28 and Pro30, and this tripeptide stretch is superimposed to other
heme-thiolate proteins. In addition, this Pro-Cys-Pro tripeptide stretch is shown to be
conserved in APOs as seen in Figure 1.7. The number of amide-sulfur hydrogen bonds in
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CPO is different than P450cam because of the adjacent residues of the proximal cysteine
in CPO are prolines, which limit the access to the backbone amide [38]. To examine the
importance of these proline residues in CPO as well as other heme-thiolate proteins, Pro28
and Pro30 were mutated to an Ala residue to examine their effects on the spectroscopic
properties of CPO.

Figure 2.1 The hydrogen bonding networks in the proximal pocket of CPO.
Ultraviolet-Visible spectrophotometry can examine the electronic structural properties
of the catalytic heme center and its surrounding. A typical UV-Vis spectrum of a heme
protein is distinguished by the two regions, near-ultraviolet and visible regions. These two
regions corresponded to two type of bands which are the Soret or B band and the Q-bands.
The Soret band originated from the transition of the ground state to the second exited state
that absorb in between 380-500 nm. As for the Q-bands, the weak transition from the
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ground state to the first excited state was observed and occasionally, multiple absorption
peaks between 500-750 nm are observed [128]. The change or shift of these absorption
peaks indicates the change in the heme environments such as the coordination and the spin
state of the heme iron. Therefore, the comparison of WT-CPO and the CPO mutants will
provide valuable insight on the effects of these proline residues on the enzyme’s electronic
properties. Besides UV-Vis spectrophotometry, circular dichroism has been commonly
used to estimate the protein’s secondary structure composition and to observe structural
changes in different conditions. Spectra’s data can be analyzed by different programs such
as CONTINLL, SELCON3, CDSSTR, VARSLC and K2D to estimate the secondary
structure [129].
Aim of this study
In the present study, Pro28 and Pro30 were mutated to an Ala residue through sitedirected mutagenesis. Three CPO mutants, P28A-, P30A-, and P28A/P30A-CPO, were
expressed and purified for spectroscopic characterization relative to WT-CPO. This
investigation revealed the importance of this conserved Pro-Cys-Pro stretch or the function
of these proline residues in the proximal loop of CPO which is applicable to other hemethiolate proteins for maintaining its structural properties.
2.2 Materials and Methods
Materials
The expression of the CPO mutant take place through the MGG029 strain of
Aspergillus niger and this strain was purchased from America Type Culture Collection
(ATCC) (Manassas, VA). The expression vector, pCPO3.I-Amds, and co-transformation
plasmid, pAB4.1, containing PyrG selection marker were obtained from TNO
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Microbiology and Systems Biology, Netherlands. The site-specific mutagenesis of
pCPO3.I-Amds was performed through the QuikChange II XL site-directed mutagenesis
kit and Q5 site-directed mutagenesis kit from Stratagene (La Jolla, CA) and New England
BioLabs (Ipswich, MA), respectively. Restriction enzymes were also purchased from New
England BioLabs (Ipswich, MA). Purified oligonucleotide primers were purchased from
Eurofins Genomics (Louisville, KY). De-ionized water for all experiments were prepared
freshly by Milli-Q Biocel (Millipore, Billerica, MA). All other chemicals and materials
were purchased from Fisher Scientific (Waltham, MA) unless otherwise stated.
2.2.2

Construction of P28A-, P30A-, and P28A/P30A-CPO genes

The pCPO3.1-AmdS vector was used for site-directed mutagenesis (Figure 2.2). This
expression vector was encoded with a full-length CPO coding sequence controlled by an
Aspergillus niger glucoamylase promoter, Aspergillus nidulans trpC terminator, pUC19
vector sequence, and an A. nidulans AmdS selection marker. The pUC19 vector sequence
allows multiple-copy production in Escherichia coli and A. nidulans AmdS selection
marker enable selection in polyacrylamide plate. The mutation(s) were introduced through
polymerase chain reaction amplification using the mutagenesis kits listed in the previous
section. The PCR reactions were carried out in Eppendorf thermal cycler (Mastercycler
gradient). The compositions of the PCR reaction are listed in Table 2.1. The primers used
for the PCR reactions are listed in Table 2.2.
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Table 2.1 PCR reaction’s composition.
Reagent

Amount

Q5 Hot Start High-Fidelity 2X Master Mix 12.5μL
Forward Primer

125ng

Reverse Primer

125ng

Template DNA

1-25ng

DI-Water

x μL (Final Volume: 25 μL)

Table 2.2 CPO mutant’s primers.
Proximal Mutant CPO
P28A-sense
P28A-antisense
P30A-sense
P30A-antisense
P28A/P30A-sense
P28A/P30A-antisense

Primers
5’GACTCTCGTGCTGCCTGCCCAGCT3’
5’AGCTGGGCAGGCAGCACGAGAGTC3’
5’CGTGCTCCTTGCGCCGCTCTGAACGCT3’
5’AGCGTTCAGAGCGGCGCAAGGAGCACG3’
5’CTCTCGTGCTGCCTGCGCCGCTCTGAACGCT3’
5’GGATGTGTCGTGCTCGGCAGCGTGGGGCTCGGC3’

Figure 2.2 Plasmids used in fungal transformation. (A) pCPO3.I-AmdS plasmid
containing A. niger glucoamylase promoter (PglaA), CPO gene from C. fumago, A.
nidulans anthranilate synthetase terminator (TtrpC), and A. nidulans acetamidase
gene (AmdS). (B) pAB4-1 plasmid containing A. niger PyrG gene and pUC 19 vector.
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The PCR condition for each cycle is 98.0°C denaturation for 50 seconds, 60.0°C
annealing for 50 seconds, and 72.0°C extension for 14 minutes. A total of 25 cycles were
performed with the final extension of the reaction 72.0°C extension for 7 minutes then the
reaction was held at 4.0°C. The PCR product was digested with Dpn I restriction
endonuclease to remove the methylated DNA template leaving behind the mutated DNA.
The PCR product was transformed into Escherichia coli (Dh5α strain) and plated on LBcarbenicillin agar plates for selection. Each mutation was confirmed through DNA
sequencing and restriction enzymes digestion along with electrophoresis (Figure 2.3 and
2.4).

Figure 2.3 DNA Electrophoresis of Restriction digestion of pCPO3.I-AmdS. Lane 1undigested DNA, Lane 2-NotI, Lane3-HindIII.
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Figure 2.4 DNA Sequencing of (A) P28A-, (B) P30A-, and (C) P28A/P30A-CPO
2.2.3

Transformation of mutant plasmid into Aspergillus niger

The mutant plasmid is transformed into A. niger MGG029 strain along with pAB4.1
through the previously described procedure with the following modifications [56]. Brown
conidiophores of MGG029 were inoculated in 50-mL minimal medium (MM) containing
0.5% yeast extract, 0.5% Casamino acids, 5% maltose, 1% glucose, 70 mM NaNO3, 7 mM
KCl, 6 mM KH2PO4, 6 mM K2HPO4, 2 mM MgSO4, 10 mM uridine, 25 µL of carbenicillin
(100 mg/mL stock), 50uL of the Hunter trace elements solution. The 50-mL culture was
incubated at 37°C and 250 rpm for 24-48 hours then the temperature is lowered to 30°C
for 48-72 hours until white-yellow mycelium is observed. Afterward, the 50-mL culture is
disrupted and transferred to 1-L MM in a 2L flask. The 1-L culture was continued to be
incubated in the same condition for another 16-20 hours. The mycelium was filtered
through sterile miracloth and resuspended in 1.7 Osm solution (270 mM CaCl2 and 600
mM NaCl) in 1g of mycelium per 20 mL. The resuspended protoplasts were digested by
150 mg lysing enzyme Sigma L-1412 for 4.0-4.5 hours at 150 rpm and 37°C. The digested
protoplasts were resuspended and incubated on ice for 20 minutes. The digested protoplasts
were collected through centrifugation (3500 rpm, 15 minutes, 0°C) and washed twice with
STC 1700 (1.2 M sorbitol, 10 mM Tris-HCl at pH 7.50, 50 mM CaCl2, 35 mM NaCl). The
protoplasts were resuspended in the leftover of STC1700 during the washing process. The
protoplast suspension is mixed with 10 μg mutant plasmid and 1 μg of pAB4.1 then the
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solution was incubated at 25°C for 25 minutes. The DNA-protoplast mixture was mixed
with 60% PEG4000 in 10 mM Tris-HCl at pH 7.50 and 50 mM CaCl2 and then incubated
at 25°C for 20 minutes. The polyethylene glycol-treated protoplast suspensions were
diluted by 5-10 mL of STC1700. The protoplasts were collected and resuspended with
STC1700. The suspension was plated on 1.2 M sorbitol acrylamide selective plate and
successful transformants were used for protein expression [55].
2.2.4

Expression and Purification of P28A-, P30A-, and P28A/P30A-CPO.

The colonized acrylamide plates were cultured in MM lacking uridine, yeast extract,
maltose, and glucose containing 10% fructose and 100 µM δ-aminolevulinic acid. Cultures
were incubated in a rotary shaker at 250 rpm and 25°C for 2 days. On the third day, the
temperature was lowered to 22°C (the optimal temperature for the CPO mutant
expression), for 5additional days. Different assays, described in the later section, were used
to monitor the production of the CPO mutant(s).
The cultures were filtered through Fisherband glass fiber filter circles G6. The filtrate
was concentrated to 30mL through Amicon high-pressure cells with 30 kDa filter
membrane cutoffs. After concentrating the medium, the sample was dialyzed against 4L
buffer A (25 mM phosphate buffer, pH 5.90) overnight with at least one-time change of
buffer. The sample was filtered through 0.45 μm filter and subjected to two types of
chromatography, ion-exchange and size exclusion.
For ion-exchange, the column was packed with diethylaminoethanol (DEAE)
sepharose and equilibrate with buffer A. The sample was injected into the column and
washed with buffer A while gradually increasing, 0-0.50 M, NaCl concentration. When the
protein eluted, a dark green/red color is observed. Eluted fractions with Reinheitzahl (Rz)-
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(A420/A280) values above 0.7 were combined and concentrated to approximately 1 mL
through the Millipore 30,000 Da centrifugal filter unit. The concentrated fractions were
further purified through the size exclusion column packed with Sephadex G75 resin.
Similarly, the eluted fractions with the highest (Rz≈1.2-1.4) Rz-value were combined and
concentrated for analysis (Figure 2.5).

Figure 2.5 Eluted fractions collected after gel-filtration chromatography.
2.2.5

UV-Visible spectroscopic characterization of CPO mutants

A VARIAN UV-Vis spectrophotometer (Cary 300 Bio) was used for the all the UVVis spectroscopic analysis of CPO. The UV-Vis absorption spectra of WT-CPO and the
CPO mutants were taken in 50 mM phosphate buffer at pH 2.50-6.00 throughout the
wavelength of 200-800 nm using 1-cm quartz cuvettes.
2.2.6

Ligand Binding Study

Absorption spectra was taken for mutant and WT-CPO in the absence and presence of
exogenous ligands, CN- and CO.
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2.2.6.1 Carbon Monoxide
For carbon monoxide binding, spectra of the native, reduced, and CO-bound of WTCPO and the mutants were recorded. The ferric enzyme was reduced to ferrous state
through the addition of sodium dithionite. The reduced enzyme was then saturated with
CO for a minute for the binding to the heme iron.
2.2.6.2 Cyanide
For cyanide binding, spectra were recorded for WT-CPO and the mutants in 50 mM
phosphate buffer at pH 5.9 titrating with increasing concentration, 0-50 mM, of cyanide.
The binding affinity was calculated with the following equations [130]:

𝐾𝑑 =

[𝐶𝑃𝑂][𝐶𝑁 − ]
[𝐶𝑃𝑂(𝐶𝑁)]

(1)

where [CPO] and [CN -] are the concentration of free CPO and free cyanide, respectively,
and [CPO(CN)] is the concentration of the complex.
The ratio of the concentration of the complex relative to the total concentration of CPO,
[CPO]0 is represented by α:

𝛼=

[𝐶𝑃𝑂(𝐶𝑁)]
[𝐶𝑃𝑂]0

=

[𝐶𝑃𝑂(𝐶𝑁)]
[𝐶𝑃𝑂]+[𝐶𝑃𝑂(𝐶𝑁)]

(2)

Combining equation (1) and (2):

𝛼=𝐾

[𝐶𝑁 − ]
𝑑 +[𝐶𝑁

−]

(3)

The change in the absorbance intensity of CPO(CN) complex formation was used as an
indication of the formation of the complex. Then equation (2) and (3) can be rewritten as:
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𝛼=

𝛥𝐴𝐶𝑃𝑂(𝐶𝑁)
𝛥𝐴𝑚𝑎𝑥

=

[𝐶𝑁− ]
𝐾𝑑 +[𝐶𝑁− ]

(4)

Assuming [CN-]=[CN-]0, equation (4) can be modified as:

𝛥𝐴𝐶𝑃𝑂(𝐶𝑁) =

𝛥𝐴max [𝐶𝑁 − ]0
𝐾𝑑 +[𝐶𝑁 − ]0

(5)

Afterward, plotting equation (5) is used to estimate the values of ΔAmax. Then, ΔAmax is
used to determine Kd through equation (4).
2.2.7

Circular dichroism spectroscopy

A JASCO spectrometer was used to obtain the CD spectra for 1.3 µM WT- and the
mutants in 50 mM phosphate pH 5.90. The spectrum recorded in between the range of 190300 nm to monitor the proteins. The CDSSTR method is used to determine the secondary
structure’s composition. This method performs calculations on the secondary structure
composition with a set of reference proteins and those that does not match the characteristic
of the sample protein were removed from the reference set.
2.3 Results
UV-Visible spectroscopic properties of WT-, P28A-, P30A-, and P28A/P30ACPO
The UV-Vis absorption spectra of WT-, P28A-, P30A-, and P28A/P30A-CPO provided
the spectroscopic signature of the enzymes and revealed important information on the heme
center. In Figure 2.6, the black line represented the spectrum of WT-CPO and it clearly
shows the Soret peak at 398 nm as well as β and α peaks at 515 and 545 nm, respectively.
The Soret and β peak as observed for WT-CPO has been used to characterize the ferric
heme protein to be penta-coordinated as a high-spin species [62].
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The Soret peak of the CPO mutants is at 420 ± 1 nm while β and α peaks are located
around 540 and 570 nm, respectively (Table 2.3). These shifted peaks suggested the
presence of a distal ligand bound to the ferric heme existing in a low-spin hexacoordinate
state. Similar spectra have been observed for WT-CPO when the enzyme was cooled to 77
K, implicating that the protein goes through a high-spin to low-spin transition as
temperature changes [62]. In addition, the three CPO mutants displayed a clear δ-band at
~362 nm which provided additional support for the presence of a low-spin heme iron. The
peak at ~650 nm is known as the ligand to metal charge transfer (LMCT) peak and has
been proposed to act as a high-spin state marker for heme-thiolate proteins. The intensity
of the LMCT peak for the mutants was relatively low as compared to WT-CPO indicating
the different spin-state.

Figure 2.6 UV-Vis Spectra of WT-, P28A-, P30A-, and P28A/P30A-CPO in 50 mM
phosphate buffer, pH 5.90.
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Table 2.3 UV-Vis Spectral properties of WT-CPO and the CPO mutants.
Proteins

δ-band

WT-CPO

Soret band β-band

α-band

CT-band

--

398 nm

516 nm

547 nm

649 nm

P28A-CPO

354 nm

420 nm

539 nm

569 nm

650 nm

P30A-CPO

~362 nm

420 nm

540 nm

570 nm

649 nm

P28A/P30A-CPO

~362 nm

420 nm

538 nm

569 nm

651 nm

A possible identity for the distal ligand of the low-spin species could be a water
molecule as the spectra of the CPO mutants resembled that of camphor-free P450cam;
however, an amino acid in the distal pocket could also be possible. To investigate the
properties of the distal ligand as well as the influence of pH on the structure of the CPO
mutants, pH studies on P28A-, P30A-, and P28A/P30A-CPO were performed in phosphate
buffer as shown in the next section.
2.3.2

pH study on P28A-, P30A-, and P28A/P30A-CPO

Based on previously reported studies, WT-CPO is stable and the heme iron remains in
high-spin state at pH 2.50-6.00. However, the UV-Vis spectra of the CPO mutants at pH
2.50-6.00 showed otherwise. The low-spin heme iron of P28A-and P30A-CPO is stable at
pH higher than 3.00. As pH 3.00, the Soret peak (420 nm) decreased as a peak around 398
nm began to form (Figure 2.7 and 2.8). This low-spin to high-spin transition is better
observed as pH 2.50 where double peaks were observed in the Soret band. The double
peaks indicated the presence of mixed state where the distal ligand began to be protonated.
This transition revealed the distal ligand has a really acidic pKa (below 3.00). The low pKa
of the distal ligand is quite unusual for a water molecule; however, computational studies
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have suggested that the proximal region of CPO can downregulate the pKa of the heme
distal ligand. As for the double mutant, P28A/P30A-CPO similar result was observed
throughout the tested pH range (Figure 2.9). Interestingly, this acidic ligand of
P28A/P30A-CPO seems to have a lesser competing effect on the cyanide binding relative
to the two single mutation mutants as illustrated in section 2.3.4.

Figure 2.7 UV-Vis Absorption Spectra of P28A-CPO at pH 2.50-6.00.
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Figure 2.8 UV-Vis Absorption Spectra of P30A-CPO at pH 2.50-6.00.

Figure 2.9 UV-Vis Absorption Spectra of P28A/P30A-CPO at pH 2.50-6.00.
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2.3.3

Carbon Monoxide Binding Study on WT-, P28A-, P30A-, and P28A/P30ACPO

The name of P450 originated from the Soret peak of the carbonmonoxy complex at
~450 nm when carbon monoxide is bound to the enzyme. This characteristic was conserved
in heme-thiolate proteins and has been used as an indicator for detecting the presence of a
heme thiolate-ligation. The spectra of the carbonmonoxy complex of P28A-, P30A-, and
P28A/P30A-CPO were similar to that of WT-CPO (Figure 2.10, 2.11, 2.12, and 2.13 and
Table 2.4). Even though the spin state of the ferric WT-CPO and the CPO mutants was
different, their Soret band was shifted to 408 nm after the reduction of the heme iron. The
spectra of the P28A-CO, P30A-CO, and P28A/P30A-CO complexes were almost identical
to the WT-CPO-CO complex with the Soret peak near 445 nm. Therefore, the mutation(s)
did not induce a change on the identity of the proximal ligand in CPO.

Figure 2.10 UV-Vis Absorption Spectra of ferric, ferrous and CO-bound WT-CPO.
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Figure 2.11 UV-Vis Absorption Spectra of ferric, ferrous and CO-bound P28A-CPO.

Figure 2.12 UV-Vis Absorption Spectra of ferric, ferrous and CO-bound P30A-CPO.
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Figure 2.13 UV-Vis Absorption Spectra of ferric, ferrous and CO-bound P28A/P30ACPO.
Table 2.4 UV-Vis spectral properties of ferrous and CO-bound WT-CPO and CPO
mutants.
Proteins

Soret band

β-band

Ferrous WT-CPO

408 nm

546 nm

Ferrous-CO complex WT-CPO

445 nm

550 nm

Ferrous P28A-CPO

406 nm

551 nm

Ferrous-CO complex P28A-CPO

444 nm

548 nm

Ferrous P30A-CPO

408 nm

545 nm

Ferrous-CO complex P30A-CPO

444 nm

550 nm

Ferrous P28A/P30A-CPO

409 nm

549 nm

Ferrous-CO complex P28A/P30A-CPO

444 nm

549 nm
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2.3.4

Cyanide Binding Study on WT-, P28A-, P30A-, and P28A/P30A-CPO

Cyanide is a known ligand that binds to heme proteins. As a weakly acidic ligand,
cyanide binds to CPO as HCN and then deprotonate to CN - during the ligation to the heme
iron. Upon binding to CPO, cyanide converts the high-spin ferric heme iron to a low-spin
state. The binding of this exogenous ligand to P28A-, P30A-, and P28A/P30A-CPO were
evaluated and compared to that of WT-CPO. The binding of cyanide to WT-CPO was
supported by the shift of the Soret peak from 398 nm to 441 nm and only one isosbestic
point was observed throughout the titration (Figure 2.14). The single isosbestic point at
426 nm indicates the equilibrium between free and cyanide bound CPO and the calculated
dissociation constant (Kd) for WT-CPO is 0.068 mM.
When 2 mM CN- is added to P28A-CPO, the Soret peak at 420 nm began to shift to
434 nm (Figure 2.15). The absorbance of the new Soret peak increased as the titration
procced. During the titration, an isosbestic point at 429 nm is observed which indicates the
change between free and bound states. The dissociation constant (Kd) for P28A-CPO was
calculated to be 7.4 mM which is significantly greater than WT-CPO. Therefore, cyanide
bound to P28A-CPO with a lower affinity than WT-CPO.
Similar spectra were observed for P30A-CPO as seen in Figure 2.16, the Soret peak
shifted with the addition of cyanide. The new Soret peak at 439 nm increased when the
concentration of the titrated cyanide increased. However, no clear isosbestic point was
observed throughout this titration. The calculated K d for P30A-CPO is 4.9 mM which is
lower than P28A-CPO but still much higher than WT-CPO. A possible explanation for the
decrease in the affinity of cyanide for the mutants relative to WT-CPO is that the mutants
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exist in a low-spin state rather than high-spin. Therefore, cyanide must compete with the
existing ligand thus the Kd increased for the CPO mutants.
Interestingly, the double mutant, P28A/P30A-CPO, has the lowest Kd of 0.91 mM
among the three CPO mutants. The Soret at 420 nm shifted to 435 nm as the concentration
of CN- increased as observed in Figure 2.17. Similar to P30A-CPO, no clear isosbestic
point is observed for the double mutant. Therefore, mutation on any of the proline residues
adjacent to the proximal cysteine will alter the binding affinity of cyanide toward the heme
center as summarized in Table 2.5.

Figure 2.14 Titration of cyanide onto WT-CPO in 25 mM phosphate buffer pH 5.90.
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Figure 2.15 Titration of cyanide onto P28A-CPO in 25 mM phosphate buffer pH 5.90.

Figure 2.16 Titration of cyanide onto P30A-CPO in 25 mM phosphate buffer pH 5.90.
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Figure 2.17 Titration of cyanide onto P28A/P30A-CPO in 25 mM phosphate buffer
pH 5.90.
Table 2.5 Dissociation Constant of WT-, P28A-, P30A- and P28A/P30A-CPO in 25
mM phosphate buffer pH=5.90.
Protein

Dissociation Constant

WT-CPO

0.068 mM

P28A-CPO

7.4 mM

P30A-CPO

4.9 mM

P28A/P30A-CPO

0.91 mM
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Figure 2.18 Kd determination for the CPO mutants (WT-CPO is not shown in this
figure, but similar method was used to determine the dissociation constant).
2.3.5

Circular Dichroism Spectroscopy of WT, P28A, P30A, and P28A/P30A CPO

To further investigate whether the change in the binding affinity is correlated to a
structural change induced by the mutation, the secondary structure composition of the CPO
mutants was determined through circular dichroism spectroscopy. The CD-spectrum of
WT-CPO revealed that the secondary structure of this enzyme was comprised of
approximately 34% and 22% of alpha-helices and beta-sheet, respectively (Figure 2.19 &
Table 2.6). For P28A- and P30-CPO, the alpha-helices were approximately 31% and 28%,
respectively. The beta-sheets were estimated to be 22% and 23% for P28A- and P30ACPO, respectively. These two mutations seem to cause a disruption on the secondary
structure of CPO with less than 6% difference in alpha-helices and barely any difference
in beta-sheets composition. The difference in catalytic activities, as explained in the next
chapter, and binding affinity can be caused by the change in the α-helix dipole in helix A.
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Therefore, the mutation might induced a change in the tertiary structure of the mutants,
such as the orientation of the proximal helix, that could lead to the increase or decrease in
redox potential and binding affinity.

Figure 2.19 Secondary CD Spectra of 1.3 μM WT and mutant CPO in 25 mM
phosphate buffer, pH 5.90.
Table 2.6 Secondary Structure Composition of WT-, P28A-, P30A- and P28A/P30ACPO in 25 mM phosphate buffer pH=5.90.
Protein
WT-CPO
P28A-CPO
P30A-CPO
P28A/P30A-CPO

α-helix
34%
31%
28%
45%

β-sheet
22%
22%
23%
34%

Interestingly, the CD-spectrum of the double mutant, P28A/P30A-CPO, displayed
significant difference than that of the other two mutants. The secondary composition of
P28A/P30A-CPO is 45% and 34% for alpha-helices and beta-sheet, respectively. As
compared to WT-CPO, there were greater than 10% increase for both alpha-helices and
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beta-sheet composition for the double mutant. The crystal structure of CPO revealed that
these proline residues are adjacent to a different hydrogen bonding networks, as Pro28 is
adjacent to the hydrogen bonding network form between Arg26-Asn37 and Ala27-Asn33
while Pro30 is adjacent to the amide-sulfur hydrogen bonding network form between
Ala31, Leu32, and Cys29. It is possible the mutation on Pro28 or Pro30 would disturb only
the adjacent hydrogen bonding network while the double mutants would distort both
hydrogen bonding networks thus result in a significant change in the secondary structure
of CPO.
2.4 Conclusion
The Pro-Cys-Pro tripeptide stretch within the proximal region of CPO is found to be
conserved in other heme-thiolate proteins such as UPOs. The proximal region of heme
enzymes have been proposed to play an important role in modulating their catalytic
reactivity as well as maintaining their structural properties. In the present study, we mutated
the proline residues, Pro28 and Pro30, adjacent to the proximal cysteine of CPO to an
alanine to examine their effects on the enzyme’s structural properties. Three mutants,
P28A-, P30A-, and P28A/P30A-CPO, were designed and characterized with spectroscopic
techniques.
My results revealed that the CPO mutants at ferric state exist as a low-spin hexacoordinated species with the Soret peak at 420 nm while WT-CPO, Soret peak at 398nm,
is at a high-spin penta-coordinated state. The low-spin state of the three mutants were
further supported by the presence of the δ-band at 354 nm, 362 nm, and 326 nm for P28A, P30A-, and P28A/P30A-CPO, respectively. Further investigation on the properties of the
sixth-coordinated ligand of the three mutants revealed the displacement of the distal ligand
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occur at pH less than 3.00 as supported by the double peaks, which indicated the presence
of mix state. The UV-Vis spectra of the CPO-mutants showed resemblance to the resting
state of substrate-free P450cam, suggesting the identity of the distal ligand can possibly be
a water molecule.
Ligand binding study revealed that the presence of a distal ligand for the CPO mutants
influences the binding affinity of cyanide to the heme iron. The calculated Kd of CN- for
P28A/P30A-CPO is significantly lower than that of P28A- and P30A-CPO. However, the
readily high-spin state of WT-CPO allows CN- to bind more tightly to the heme center
relative to the CPO mutants. Therefore, Pro28 and Pro30 are greatly important in
maintaining the coordination state of the heme center and mutation of these residues will
dramatically changes the binding affinity of exogenous ligand to the ferric heme iron.
Carbon monoxide only bind to the ferrous heme iron to form the carbonmonoxy
complex. The binding of carbon monoxide has been employed to probe the proximal ligand
of heme proteins as they exert different Soret band. The signature Soret maximum at ~445
nm for the carbonmonoxy complexes of the CPO mutants confirmed the presence of a
thiolate-ligation. CD spectra of WT-CPO and the CPO mutants revealed that mutation on
Pro28 or Pro30 have only a minimal effect on the enzyme’s secondary structure
composition. However, P28A/P30A-CPO displayed a significantly change in the CD
spectrum. This significant change could be the result of the distortion of the proximal
hydrogen bonding networks, the amide-sulfur hydrogen bonding network and the proximal
loop hydrogen bonding network between Arg26-Asn37 and Ala27-Asn33. As these
hydrogen bonding networks are adjacent to Pro28 and Pro30, mutations on the proline
residues can disturb the networks which would lead to a significant change in the secondary
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structure. Therefore, my work indicates that Pro28 and Pro30 have a significant impact on
the maintaining the structural properties of CPO as mutation of these proline residues can
induce a change in the proximal helix affecting its interaction with the protein matrix as
well as disturbing the adjacent hydrogen bonding networks. Such changes in the structural
properties would most likely to influence the biochemical properties of CPO as they will
be discussed in the next chapter.

58

CHAPTER III.
INFLUENCE OF THE PRO-CYS-PRO TRIPEPTIDE IN THE PROXIMAL
LOOP ON THE CATALYTIC PROPERTIES OF CHLOROPEROXIDASE
3.1 Background
CPO has been known as the most versatile heme enzymes for the past decades and this
versatility is linked to the “P450-peroxidases” hybrid structure. Many other classical heme
enzymes are mono-functional which mean they can only catalyze a particular type of
reaction such as mono-functional catalase. However, CPO can catalyze four different types
of reactions and they are peroxidation (peroxidase-like), dismutation (catalase-like),
oxygen-insertion (peroxygenase/monooxygenase-like), and halogenation (halogenaselike) reactions. Compound I is the reactive species responsible for catalyzing the different
type of reactions depending on the condition of the system.
The formation of Compound I depends on the presence of an acid-base catalyst, which
serves as the “pull effect,” and the electron-donating ability of the proximal ligand, that
acts as the “push effect” [131]. This “push-pull” effect is crucial for the formation of the
Compound I. In CPO, the “push effect” of Cys29 is regulated by the proximal helix such
as through the amide-sulfur hydrogen bonding network described in the previous chapter.
These hydrogen bonds reduced the electronegativity of the thiolate leading to the increase
on the heme iron redox potential as well as reducing the pK a of the distal ligand [11, 6369]. Pro28 and Pro30 are located adjacent to the proximal cysteine as well as the amidesulfur hydrogen bonding network. They should play a role in regulating the reactivity of
the enzyme through modulating cooperating effect between the α-helical conformation of
helix A and the amide-sulfur hydrogen bonds.
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3.1.1

Aim of this study

In this part of my study, I investigated the effect of substituting Pro28 and Pro30 with
Ala in term of CPO’s catalytic properties. Three CPO mutants, P28A-, P30A- and
P28A/P30A-CPO, were characterized through different assays targeting a specific activity
of CPO. The biochemical characterization of the CPO mutant provided us insight on the
importance of these proline residues on CPO-catalyzed one-electron (peroxidation of
ABTS) and two-electron oxidation reactions (dismutation of hydrogen peroxide,
epoxidation of styrene and halogenation of MCD). My results revealed that Pro28 and
Pro30 play a significant role in modulating the versatility of CPO where their substitution
induced significant changes on CPO’s catalytic activities.
3.2 Materials and Methods
3.2.1

Materials

All materials used are the same as those described in section 2.2.1.
3.2.2

Construction of P28A-, P30A- and P28A/P30A-CPO genes

P28A-, P30A-, and P28A/P30A-CPO were constructed with procedure similar as those
described in section 2.2.2. As for primers, they are listed in table 2.2 for the three CPO
mutants.
3.2.3

Transformation, Expression and Purification of P28A-, P30A- and
P28A/P30A-CPO plasmid in Aspergillus niger

The transformation process is similar as described in section 2.2.3. As for the
expression and purification process, the procedures were similar to that described in section
2.2.4.
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3.2.4

Enzymatic activity assays studies

3.2.4.1 ABTS Assay
Peroxidase activity of CPO was measured through the oxidation of 2, 2’-Azinobis-3ethylbenzothiazoline-6-sulfonic acid (ABTS) (Figure 3.1). The reaction system is
composed of CPO in 100 mM phosphate-citrate buffer (pH range 2.50-6.00) containing
38.9 uM ABTS. The reaction was initiated by the addition of 3.6 mM H2O2 and the rate of
peroxidation was monitored at 405 nm.
3.2.4.2 MCD Assay
MCD assay is commonly used to determine the chlorinating activity of haloperoxidase.
This assay monitors the chlorination of monochlorodimedone (MCD) to dichlorodimedone
(Figure 3.2). The reaction system is composed of CPO in 100 mM potassium-phosphate
buffer containing 20 mM KCl and 0.17 mM MCD at pH 2.50-5.00. The reaction was
initiated by the addition of 2.2 mM H2O2 while monitoring the rate of chlorination at 278
nm.
3.2.4.3 Catalase Assay
Catalase catalyzes the decomposition of hydrogen peroxide. CPO’s catalatic activity is
measured by monitoring the oxidative decomposition of hydrogen peroxide to water and
dioxygen. The reaction system is composed of 0.05% hydrogen peroxide in 50 mM
phosphate-citrate buffer at pH 2.50-6.00. The reaction was initiated by the addition of CPO
and rate of decomposition was monitored at 240 nm.
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Figure 3.1 CPO-catalyzed oxidation of ABTS

Figure 3.2 CPO-catalyzed chlorination of MCD.
3.2.4.4 Epoxidation Assay
The epoxidation assay measures the epoxidation of styrene catalyzed by CPO (Figure
3.3). The reaction system is composed of CPO in 100 mM sodium-acetate buffer at pH
2.50-6.00, containing 0.3 mM styrene and initiated by the addition of 0.01% H2O2 while
monitoring the absorbance at 262 nm.
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Figure 3.3 CPO-catalyzed epoxidation of styrene yielding R-styrene oxide and Sstyrene oxide.
3.3 Results
3.3.1

pH Profile of the Catalytic Properties of WT-, P28A-, P30A-, and
P28A/P30A-CPO

To investigate the influence of the proximal Pro-Cys-Pro tripeptide stretch on the
biochemical properties of CPO, four assays were used to characterize the difference
between the WT and mutants. They are peroxidation of ABTS, chlorination of MCD,
dismutation of H2O2, and epoxidation of styrene. These four assays were carried out
throughout different pH condition examining the effects of the residue substitution on the
catalytic activities of CPO. The specific activity for each assay were calculated with the
rate of the reaction. The rate of the reaction along with the Beer’s law was then used to
calculates the change in the amount of the substrate or product over time (second). By
dividing the amount of enzyme used for the reaction, the specific activity was calculated.
The extinction coefficients used for specific activity’s calculation for the four assays were
listed in Table 3.1.
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Table 3.1 Extinction coefficient of the Four Assays (ABTS, Epoxidation, Dismutation,
and Chlorination).
Assays

Wavelength

Extinction Coefficient (μM-1cm-1)

ABTS

405 nm

0.0368

Styrene

262 nm

1.08 x 10-3

Hydrogen peroxide

240 nm

4.36 x 10-5

Monochlorodimedone

278 nm

0.0122

3.3.1.1 Peroxidation of ABTS
ABTS assay is commonly used to measure peroxidation activity of heme peroxidase.
When ABTS is oxidized to ABTS2+, a color transition from colorless to a visible green
color is observed which this change is monitored at 405 nm as seen in Figure 3.4. In WTCPO, the optimal pH for ABTS peroxidation is at pH 2.50. The specific activity decreased
significantly at pH 3.00 and is negligible at pH 4.00 or greater. As for the mutants, the
peroxidase’s activity remained active throughout pH 2.50-5.00 with the optimal pH at 3.00.
Among the three mutants, P30A-CPO has the highest activity throughout the tested pH
range.
As stated in the introduction, the catalytic cycle of CPO contains intermediates that are
responsible for catalyzing certain reaction. In the peroxidation pathway, Compound II is
responsible for catalyzing the second one-electron oxidation of the substrate. The
peroxidase’s activity of the three CPO mutants is active at pH greater than 4.00, suggesting
the mutation within the Pro-Cys-Pro tripeptide stretch have a significant influence on the
formation of Compound I as well as Compound II.
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Figure 3.4 Peroxidation of ABTS catalyzed by WT- and P28A/P30A-CPO monitor at
405nm.

Figure 3.5 Specific activity of WT-, P28A-, P30A- and P28A/P30A-CPO for ABTS
assay at pH 2.50-6.00. (Some error bars are not visible on the graph)
As proposed in previous studies, the proximal pocket of CPO regulates the pK a of the
distal heme ligand during the formation of Compound I through the interaction of the
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proximal ligand [67]. As in the finding of Dr. Raven’s group, the nature of the ferryl species
of heme proteins is an unprotonated iron-oxo and protonated iron-oxo for Compound I and
Compound II, respectively [132]. Therefore, the regulation of the distal ligand pK a caused
by the mutation favored the formation of the active protonated Compound II species
relative to WT-CPO where significant activities were observed at pH ≥ 4.00.
3.3.1.2 Epoxidation of Styrene
WT-CPO catalyzes epoxidation reactions in a stereoselective manner and has been a
great interest in pharmaceutical and chemical fields as a potential biocatalyst candidate.
The activity of CPO in the oxygen-insertion pathway is measured through the epoxidation
assay by monitoring the decreased in absorbance at 262 nm (Figure 3.6). The specific
activity of WT-CPO for the epoxidation reaction does not have a significant change
throughout the tested pH range which suggested this type of reaction is pH-independent.
However, this does not seem to be the case for the CPO mutants. The specific activity of
P28A- and P30A-CPO increased significantly as the pH rise (Figure 3.7). This trend
suggested the mutation on Pro28 caused a greater influence on the epoxidation activity of
CPO relative to Pro30 mutation. As observed, the double mutant, P28A/P30A-CPO,
displays similar epoxidation activity trend along the pH range as to the other two mutants.
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Figure 3.6 Epoxidation of Styrene catalyzed by WT- and P30A-CPO monitor at
262nm.

Figure 3.7 Specific activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
Epoxidation assay at pH 3.00-5.50. (Some error bars are not visible on the graph)
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3.3.1.3 Dismutation of Hydrogen Peroxide
Hydrogen peroxide is a common oxidant utilized by peroxidase to carried out oxidative
reactions. However, excessive amount of this oxidant can lead to deleterious effects. A
type of enzyme that remove excess oxidant is known as catalase. CPO’s dismutation
pathway limits the amount of hydrogen peroxide for the formation of Compound I. To test
the catalatic activity of WT-, P28A-, P30A- and P28A/P30A-CPO, the rate of dismutation
of hydrogen peroxide was measured by monitoring the change in the absorbance at 240 nm
as observed in Figure 3.8. This study shown that WT-CPO’s catalatic activity remains
active throughout pH 2.00-6.00. However, when pH falls below 2.00, no activity was
observed. As for P28A-CPO, no significant catalatic activity was observed within the
tested pH range. Similar result was also observed for P28A/P30A-CPO where the activity
is negatable as shown in Figure 3.9.
However, P30A-CPO retained significant catalatic activity only at pH 5.00 and 6.00.
The results suggested that Pro28 has a significant contribution to the dismutation activity
of CPO as mutation on this residue hindered the dismutation pathway as illustrated by
P28A- and P28A/P30A-CPO. Pro30 play a subtler role relative to Pro28 in modulating the
catalatic activity of CPO, as the mutation only reduced the dismutation activity. The
mutation(s) on Pro28 and Pro30 might influenced the helix-dipole moment resulting in the
decrease of the reduction potential of the mutants’ Compound I intermediate thus
prohibiting the oxidation of the second hydrogen peroxide.
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Figure 3.8 Dismutation of hydrogen peroxide catalyzed by WT- and P30A-CPO
monitor at 240nm.

Figure 3.9 Specific activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
Epoxidation assay at pH 2.00-5.50. (Some error bars are not visible on the graph)
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3.3.1.4 Halogenation of Monochlorodimedone
MCD assay has been used to estimate the amount of CPO during the expression of this
enzyme. In this assay, monochlorodimedone is chlorinated into dichlorodimedone which
is measured through the decrease of absorbance at 278 nm as observed in Figure 3.10. WTCPO’s chlorinating activity is most active at pH 2.75 and the rate of the reaction decreased
dramatically as pH rise. As for the mutants, no sign of chlorinating activity was observed
(Figure 3.11). In this type of reaction, the redox potential of the halides need to be
considered as whether the catalytic reaction can proceed. Considering the standards redox
potential of the half reactions for hydrogen peroxide and the halides, as observed in Table
3.2. The oxidative capability of hydrogen peroxide is sufficient in oxidizing halides besides
fluoride as no halogenase or haloperoxidase was known to catalyze fluorination reaction
[72]. This suggested that CPO-I should contain a positive redox potential that is greater
than that of hydrogen peroxide as CPO contains catalatic activity but lower than that of
oxidizing fluoride. To investigate whether the redox potential of the CPO mutants was
decreased and rendered the abolishment of the halogenating activity, the activity was
further investigated with substituting the chloride ions in the MCD assay with bromide
ions.
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Figure 3.10 Chlorination of MCD catalyzed by WT- and P30A-CPO monitor at 278
nm.

Figure 3.11 Specific activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
chlorination of MCD assay at pH 2.00-6.00. (Some error bars are not visible on the
graph)
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Table 3.2 Half-reactions with redox potential of hydrogen peroxide and halide ions.
Half-Reaction
H2O2 + 2H+ + 2e- → 2H2O
2F- → F2 + 2e2Cl- → Cl2 + 2e2Br -→ Br2 + 2e2I- → I2 + 2e-

E0, Volts
+1.77
-3.06
-1.36
-1.07
-0.54

As the reduction potential requires to oxidizes bromide ions is less than that of chloride
ions, higher activity should be observed as seen in previous studies for WT-CPO [86]. Our
result revealed the brominating activity of WT-CPO has about a five-fold increase relative
to the chlorinating activity, which correlates with the previously reported data. However,
the mutants still displayed no sign of halogenating activity after the bromide ions
substitution (Figure 3.12). The result revealed that the CPO mutants lost all sign of
halogenating activity. The plausible explanation might be that the redox potential has been
reduced to a level where the oxidation of bromide ion is also prohibited. An alternate
possibility for the demolish of the halogenation pathway for the CPO mutants might arise
from the changes induced on the structure of the enzyme which resulted in the disruption
of the halide-binding sites. However, the CD analysis showed no significant difference
between WT-CPO and the CPO mutants and the mutation mainly focused on the proximal
pocket where major changes in the halide-binding site seem to be less probable.
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Figure 3.12 Specific activity of WT-, P30A- and P28A/P30A-CPO for bromination of
MCD assay at pH 2.00-6.00. (Some error bars are not visible on the graph)
3.3.1.5 Relative Activities
P28A- and P28A/P30A-CPO contain no significant sign of chlorination and
dismutation activities while retaining peroxidation and epoxidation activities. Similarly,
P30A-CPO contains no sign of chlorination activity and enhanced peroxidation and
epoxidation activities but significant dismutation activity at pH 5.00 and 6.00 was
observed. Therefore, specific pH (Table 3.3) for the four assays were chosen for
comparison of the relative specific activities between WT-CPO and the CPO mutants.
These pH values were selected because they are either commonly used in studies to their
respective reactions or displayed significant difference between WT-CPO and the CPO
mutants.
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Table 3.3 pH comparison for the Four Assays (ABTS, MCD, Epoxidation, and
Dismutation).
Assays

pH

Epoxidation

5.00

Dismutation

5.00 & 6.00

MCD

2.75

ABTS

2.50 & 4.00

Overall, my results suggested that the enhancement of the epoxidation pathway of the
CPO mutants is at the expense of the dismutation activity as more of the reactive species,
Compound I, and oxidizing agent is available for catalyzing the epoxidation reaction. The
relative activity clearly demonstrated the competing relationship between the epoxidation
and dismutation pathway as observed in Figure 3.13 and 3.14. The order of epoxidation
activity from highest to lowest are P28A-, P28A/P30A-, P30A- and WT-CPO at pH 4.00
or higher. The epoxidation activity of P28A-, P30A- and P28A/P30-CPO were enhanced
by 12-, 6-, and 9-fold relative to WT-CPO at pH 5.00, respectively.
At pH 5.00, P30A-CPO retained approximately 35% catalatic activity relative to WTCPO. Among the CPO mutants, P30A-CPO was the only mutant that retained partial
catalatic activity, which explained why this CPO mutant displayed the least enhanced
epoxidation activity. However, no significant catalatic activity was observed for the
mutants at WT-CPO’s optimal pH (4.00) (Figure 3.15).
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Figure 3.13 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
Epoxidation assay at pH=5.00.

Figure 3.14 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
dismutation of hydrogen peroxide assay at pH=5.00.
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Figure 3.15 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
dismutation of hydrogen peroxide assay at pH=4.00, optimal pH for WT-CPO.
As stated in Chapter I, the proposed mechanism of the dismutation pathway may
involved the formation of the Compound I-peroxide species, which was crucial for the
decomposition of hydrogen peroxide. The mutation(s) may hinder the formation of the
Compound I-peroxide species thus result in the loss or reduction of the catalatic activity.
The results for P28A-, P30A-, and P28A/P30A-CPO suggested that mutations within the
Pro-Cys-Pro tripeptide might lead to the decrease in the redox potential of the heme center
while increasing the basicity of the distal ligand. The possible decrease in the redox
potential could explain the mutants’ disability in oxidizing hydrogen peroxide.
At pH 2.75, the optimum pH for CPO-catalyzed chlorination reactions, no significant
sign of activities for chlorination and bromination were observed for the CPO mutants as
observed in Figure 3.16. The possible decrease in the redox potential of the CPO mutants
might be the plausible explanation on the abolishment of chlorinating activity, as
Compound I is inefficient in oxidizing chloride ions. MCD assay in the presence of
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bromide ion revealed that there was no significant difference between chlorination and
bromination reaction (Figure 3.17). The approximate 0.3% relative chlorination and
bromination activities observed for the mutants were from the direct oxidation of MCD
[36].

Figure 3.16 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
chlorination, Left, and bromination, Right, of MCD assay at pH=2.75.

Figure 3.17 Relative activities of P28A-, P30A- and P28A/P30A-CPO for chlorination,
Left, and bromination, Right, of MCD assay at pH=2.75.
Both, dismutation and halogenation, pathways involves two-electrons oxidative
reactions and the possible decrease in the redox potential of the CPO mutants hindered
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these two pathways. As the redox potential decreased, the pK a of the distal ligand increased
favoring the protonation of Compound II. In the catalytic cycle of CPO, the pathway that
involves Compound II is the peroxidation pathway, a two one-electron oxidation reaction.
As shown in Figure 3.18 and 3.19, WT-, P28A-, P30A- and P28A/P30A-CPO displayed
relativity different degree of peroxidase’s activity.

Figure 3.18 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
peroxidation of ABTS assay at pH=2.50, optimal pH for WT-CPO.
At pH 2.50, WT-CPO contains the highest peroxidation activity while the CPO mutants
retained only about 30-40% of relative activity. However, the activity of the CPO mutants
is significantly enhanced at pH 4.00 or higher. For example, at pH 4.00, the activities of
P28A-, P30A- and P28A/P30A-CPO were 4-, 13- and 9-fold relative to WT-CPO,
respectively. These enhancements might possibly be the result of the lack of catalatic
activity as well as the increase in the basicity of the distal ligand. Our results suggested the
pKa of Compound II for WT-CPO and the CPO mutants is different with the latter being

78

higher. Therefore, at pH 4.00 or higher, Compound II of WT-CPO has a more difficult time
forming the protonated species.

Figure 3.19 Relative activity of WT-, P28A-, P30A- and P28A/P30A-CPO for
peroxidation of ABTS assay at pH=4.00.
3.4 Conclusion
The proximal loop of CPO has been proposed to play an important in modulating the
structural and biochemical properties of the enzyme. Within this loop, few distinctive
features highlighted the significant of CPO. The proximal loop of CPO consists of
hydrogen bonding networks that function in maintaining the structure of the helix as well
as regulating the reactivity of the enzyme. The Pro28-Cys29-Pro30 tripeptide stretch
containing the proximal ligand has been found to be conserved for heme-thiolate proteins
such as UPOs. The importance of these proline residues was investigated in my research
in which Pro28 and Pro30 in CPO were replaced with alanine to examine the effects on its
biochemical properties. The results of my study revealed that these proline residues play
an important role to regulating the catalytic properties of CPO.
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Our results indicated that mutation on Pro28 and/or Pro30 alter the optimal pH
preference of CPO-catalyzed reactions. For example, the optimal pH for WT-CPO to
catalyzes the peroxidation of ABTS is 2.50 but the optimal pH is shifted to 3.00 for P28A, P30A- and P28A/P30A-CPO. All three mutants possess no sign of chlorination activity.
In term of hydrogen peroxide dismutation, P28A- and P28A/P30A-CPO contain no sign of
catalatic activity while the activity of P30A-CPO was reduced. At the expense of the
chlorination and dismutation activities, the epoxidation and peroxidation activities of the
CPO mutants were enhanced. Especially, the epoxidation activity of the CPO mutants
displayed with multi-fold enhancement at the tested pH range of 3.00-5.50 relative to WTCPO. Based on changes in the catalytic activities of CPO, Pro28 and Pro30 might play a
role in regulating the redox potential of the heme center thus the mutation(s) resulted in the
demolition of the dismutation and halogenation activities
Based on my results, the proline residues might regulate the reactivity of CPO through
stabilizing the adjacent hydrogen bonding networks, amide-sulfur hydrogen bonding
network and the proximal helix hydrogen bonding network. These hydrogen bonding
networks have been proposed to regulates the “push” effect of the proximal ligand during
the formation of Compound I as well as the redox potential of the catalytic heme center.
The rigid nature of proline can stabilize these networks thus regulating activities such as
chlorination and peroxide dismutation. If this is the case, then the individual hydrogen
bonding network seems to contribute to a different extent to the catalytic properties of CPO.
As the mutation on Pro28 abolished the catalatic activity while the P30A-CPO retained
partial activity. Therefore, my research further our understanding on these conserved
prolines that sandwiched the proximal cysteine as they are important in modulating the
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catalytic activity of CPO, possibly through the stabilization of the adjacent hydrogen
bonding networks.
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CHAPTER IV.
MUTAGENESIS APPROACH ON THE SUBSTRATE-BINDING POCKET OF
CPO
4.1 Background
On the surface of CPO, there are two channels where the substrate can diffuse into the
active site. The bottom of the two channels form this substrate-binding pocket, which is
located above the catalytic heme center [38]. The distal pocket of CPO resembles that of
classical peroxidases as it is composed of polar residues. In heme peroxidases, the distal
region contains a conserved His residue that act as an acid-base catalyst, which facilitates
the cleavage of the peroxide bond during the formation of Compound I [24, 61, 72, 131,
133]. However, the crystal structure of CPO revealed that the closest histidine, His105, is
still too far from the heme iron to catalyze the cleavage process. Instead, Glu183 is found
to be the only polar/charged group within the distance to act as the acid-base catalyst [74].
Therefore, His105 is proposed to play a subtler role through the formation of a hydrogen
bond with Glu183 and act as proton shuttle during the cleavage of the peroxide bond. This
is also observed in classical peroxidases where instead of a histidine, an arginine residue
nearby forms a hydrogen bond with His [25, 131].
In most heme peroxidases, substrate interactions occur through the heme edge while
P450 enzymes contain a substrate-binding pocket that allow direct access to the ferryl-oxo
center. CPO resembles to that of P450, as the substrate-binding pocket is located above the
heme plane allowing the interactions between the substrate and the active site. The opening
is guarded by the sidechains of three hydrophobic residues, Phe103, Phe186 and Val182
(Figure 4.1). These three residues have been proposed to interact with the substrate,
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orienting the substrate to a specific conformation, thus lead to the enantioselectivity of the
reaction.

Figure 4.1 Substrate-binding pocket on the distal region of CPO.
Within our research lab, the contribution of Phe103 on the enantioselective reactions
was previously examined. Through site-directed mutagenesis, Phe103 is replaced by an
alanine residue increasing the space within the substrate-binding pocket of CPO thus
allowing larger substrate to access the heme center. The result from our lab indicated that
the distal pocket of CPO has a dramatic effect on the enzymatic activities as the mutant,
F103A-CPO, displayed at least 4-fold enhancement of peroxygenase activity at the expense
of the catalase activity. In term of enantioselectivity, F103A-CPO catalyzes epoxidation of
long-side chain styrene derivatives with greater enantioselectivity relative to WT-CPO
[124]. This mutant revealed the importance of Phe103 on the enantioselective reactions
catalyzed by CPO.
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Phe103 is flexible in the substrate-binding pocket, as the binding of CPD to the active
site of CPO resulted in the displacement of Phe103 by 0.5Ǻ away from the active site to
accommodate the substrate [70]. In addition, another phenylalanine, Phe186 has been
proposed to play a similar role as Phe103; however, Phe186 is intact during the binding of
CPD. To better understand the importance of Phe186 on CPO’s catalysis, I investigated
the role of Phe186 in the substrate-binding pocket through site-directed mutagenesis. In
addition, a double mutant, F103A/F186A-CPO, was designed and characterized to further
our understanding on the importance of these two residues on the effect on substrate
selectivity and their enantioselectivity.
To investigate the substrate selectivity and their enantioselectivity, HPLC was
employed for chiral separation of the extracted enantiomers. HPLC stand for high
performance liquid chromatography and has been used for purifying chemicals and
proteins [134]. Within liquid chromatography, there are two types of phases, stationary and
mobile. The stationary phase is associated with the column of the HPLC and is selected
based on the nature of the analyte. In this case, our study used the Whelk-O 1 column.
Whelk-O 1 was selected because this column utilized a brush-type chiral stationary phase
that function through a three-point interaction mechanism [135]. These interactions are ππ stack formed with the dinitrophenyl group, hydrogen bonding interactions, and either
CH-π interactions [136] or edge-to-face π-π interactions [137]. In my study, hexane is used
as mobile phase while the epoxide products of CPO-catalyzed epoxidation of styrene and
its derivatives listed in Table 4.1 were extracted with isooctane. Therefore, the Whelk-O 1
column’s tolerance against organic solvents as well as aqueous systems is crucial for my
study.
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Table 4.1 Styrene and its derivatives and their corresponded epoxide products
Substrate
Styrene

Epoxidation products
(R)-Styrene oxide

(S)-Styrene oxide

Cis-β-methylstyrene

(1R,2S)-Cis-β-methylstyrene oxide

Trans-β-methylstyrene

(1R,2R)-Trans-β-methylstyrene oxide (1S,2S)-Trans-β-methylstyrene oxide

Trans-β-ethylstyrene

(1R,2R)-Trans-β-ethylstyrene oxide

Trans-β-propylstyrene

(1R,2R)-Trans-β-propylstyrene oxide
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(1S, 2R)-Cis-β-methylstyrene oxide

(1S,2S)-Trans-β-ethylstyrene oxide

(1S,2S)-Trans-β-propylstyrene oxide

4.1.1

Aim of this study

In my study, Phe103 and Phe186 were mutated to an Ala residue, removing the phenyl
sidechain, thus allowing bulkier substrate to bind to the pocket. Through site-directed
mutagenesis, two CPO mutants, F186A- and F103A/F186A-CPO, were generated and
characterized relative to WT-CPO and F103A-CPO. These mutants further our
understanding on the importance of these two residues on the effect on the stereoselectivity
of CPO-catalyzed epoxidation reactions as well as the selectivity of the substrates.
4.2 Material and Methods
4.2.1

Construction of F186A- and F103A/F186A-CPO genes

F186A- and F103A/F186A-CPO were constructed with procedure similar as those
described in section 2.2.2. As for primers, they are listed in Table 4.2 for the two CPO
mutants. DNA sequencing results of the two mutant plasmids were shown in Figure 4.2.
Table 4.2 CPO distal mutant’s primers.
Proximal Mutant CPO

Primers

F186A-sense

5’CGTCGAGTCTGGCGCCATCTTCGCCCTTG3’

F186A-antisense

5’GCGAAGATGGCGCCAGACTCGACGTTCTG3’

F103A/F186A-sense

5’ CACGCTGCCGAGCACGACCACTC3’

F103A/F186A-antisense

5’TGCTCGGCAGCGTGGGGCTCG3’
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(A)

(B)

Figure 4.2 DNA Sequencing of (A) F186A- and (B) F103A/F186A-CPO
4.2.2

Transformation, Expression and Purification of F103A- and F103A/F186ACPO plasmid in Aspergillus niger

The transformation process is similar as described in section 2.2.3 while the plasmids
used were those with the distal region mutation. Successful transformants of F186A-CPO
on the 1.2M Sorbitol plates are shown in Figure 4.3. As for the expression and purification
process, the procedures were similar to that described in section 2.2.4.

Figure 4.3 Successful transformants on 1.2 M Sorbitol acrylamide selective plate
4.2.3

Spectroscopic Characterization

The use UV-Vis spectrophotometry to characterize the mutant was similar to the
procedure described in section 2.2.5. The ligand binding study for the distal region mutants
were similar to the one described in section 2.2.6. In addition, CD spectrum was taken with
similar procedure as section 2.2.7.

87

4.2.4

Enantioselective Study

Styrene and its derivatives (cis-β-methylstyrene, trans-β-methylstyrene, trans-βethylstyrene, and trans-β-propylstyrene) were used as substrates to examine the
enantioselectivity of WT-CPO and mutants catalyzed epoxidation reactions. A substrate
mixture was prepared with 70 µL of styrene or its derivatives and 100µL of tert-butyl
hydroperoxide. The reaction was composed of 700 µL of 100 mM sodium citrate buffer,
pH 5.50, with about 2 mg of CPO and was initiated by the addition of 25 µL of the substrate
mixture. After incubated at room temperature for 3 hours, the reaction was quenched by
the addition of 50 µL of 1 M Na2S2O3 in a saturated solution of NaHCO3. The products
were extracted with 300 µL of isooctane and 20 uL of the extracts were inject to a WhelkO1-SS column with 100% hexane as mobile phase. The flow rate was set at 1 mL/min while
monitoring the absorbance at 214-220 nm.
4.2.5

Data Analysis

The HPLC results were analyzed with the following parameters:
(tR – t0 )

Retention factor: k’ =

t0

where tR is the retention time while t0 is the void time;
k

t

–t

Separation factor: α = k2’ = tR2 – t0
1’

R1

0

where k1’ and k2’ represented the retention factors of the two eluted enantiomers and tR1
and tR2 were the retention times for the two enantiomers;
Resolution factor: R s =

2(tR2 − tR1 )
(W1 +W2 )

where W1 andW2 represented the individual peak widths.
ee= % (major isomer) - % (minor isomer)
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4.3 Results
4.3.1

Circular Dichroism Spectroscopy of WT-, F186A-, and F103A/F186A-CPO

The secondary structure composition of the CPO mutants was determined through
circular dichroism spectroscopy. CD-spectra of WT-, F186A-, and F103A/F186A-CPO
were shown in Figure 4.4. As observed in Table 4.3, the difference in the secondary
structure of the proteins was not significant. The secondary structure of WT-CPO was
comprised of approximately 34% and 22% of alpha-helices and beta-sheet, respectively.
As for the CPO mutants, F186A- and F103A/F186A-CPO have a similar secondary
composition of 32% alpha-helices and 21% beta-sheets. The difference between the WTCPO and the mutants was less than 2%. Therefore, the mutation(s) of Phe103 and Phe186
to a smaller residue, Ala, does not significantly alter the secondary structure of the protein.

Figure 4.4 Secondary CD Spectra of 1.3 μM WT-, F186A-, and F103A/F186A-CPO
in 25 mM phosphate buffer, pH 5.90.
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Table 4.3 Secondary Structure Composition of WT-, F186A-, and F103A/F186A-CPO
in 25 mM phosphate buffer pH=5.90.
Protein
WT-CPO
F186A-CPO
F103A/F186A-CPO
4.3.2

α-helix
34%
32%
32%

β-sheet
22%
21%
21%

UV-Visible spectroscopic properties of WT-, F186A-, and F103A/F186ACPO and their carbonmonoxy complex

CD spectroscopy revealed no significant difference between WT-, F186A-, and
F103A/F186A-CPO. However, the UV-Visible spectroscopic characterization showed
otherwise. The UV-Visible spectrum of WT-CPO revealed that the enzyme exists as a
penta-coordinated high-spin state as observed in Figure 4.5. This ferric enzyme was
reduced to ferrous state through the addition of sodium dithionite where the Soret peak at
398 nm was shifted to 408 nm as an indication of the reduction. After reduction, carbon
monoxide can bind to the ferrous WT-CPO producing the signature spectrum of hemethiolate proteins where the Soret peak absorbed at 445 nm.
As observed in Figure 4.5 and 4.6, ferric F186A-CPO’s Soret peak absorbed at 420 nm
and this shift indicated the presence of a distal ligand as well as a hexa-coordinated lowspin species. Upon reduction, similar spectrum was observed for ferrous F186A-CPO as to
ferrous WT-CPO. The mutation did not alter the identity of the proximal ligand as the CObound complex of F186A-CPO resemble that of WT-CPO-CO complex as well as other
heme-thiolate proteins CO-bound complexes [27, 37, 138]. However, the resting state of
the mutant resemble that of P450 as a low-spin species. As for F103A/F186A-CPO, similar
spectra relative to F186A-CPO were observed for the carbon monoxide binding process as
seen in Figure 4.7. Detail of the peaks for WT-, F186A-, and F103A/F186A-CPO as well
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as the ferrous and CO-bound forms were summarized in Table 4.4.
Table 4.4 UV-Vis spectral properties of ferric, ferrous and CO-bound WT-CPO and
CPO mutants.
Proteins
Ferric WT-CPO
Ferrous WT-CPO
Ferrous-CO complex WT-CPO
Ferric F186A-CPO
Ferrous F186A-CPO
Ferrous-CO complex F186A-CPO
Ferric F103A/F186A-CPO
Ferrous F103A/F186A-CPO
Ferrous-CO complex F103A/F186A-CPO

Soret band
398 nm
408 nm
445 nm
420 nm
408 nm
445 nm
419 nm
406 nm
444 nm

β-band
516 nm
546 nm
550 nm
541 nm
551 nm
549 nm
543 nm
547 nm
549 nm

Figure 4.5 UV-Vis spectra of WT-, F186A-, and F103A/F186A-CPO in 25 mM
phosphate buffer, pH 5.90.
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Figure 4.6 UV-Vis spectra of ferric, ferrous, and CO-bound F186A-CPO in 25 mM
phosphate buffer, pH 5.90.

Figure 4.7 UV-Vis spectra of ferric, ferrous, and CO-bound F103A/F186A-CPO in 25
mM phosphate buffer, pH 5.90.
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4.3.3

Cyanide Binding Study on WT-, F186A-, and F103A/F186A-CPO

Cyanide bind to WT-CPO with high affinity, as stated in Chapter 2, the Kd is 0.068
mM. Titration of cyanide was performed on the CPO mutants and the K d was calculated.
My result revealed F186A-CPO has a dissociation constant of 6.3 mM for cyanide (Figure
4.8). The decrease in the binding affinity could be the result of a wider active site as well
as the presence of a sixth ligand, which competes with the exogenous ligand. This
explanation correlates with a previous study in our lab, that the CPO mutant, F103A-CPO,
also had a higher Kd of 4.5 mM for cyanide [124]. Interestingly, the double, F103A/F186A,
mutant displayed a Kd of 3.6 mM which is lesser than that of the two single mutation
mutants. However, this Kd value is still significantly greater than that of WT-CPO.

Figure 4.8 Titration of cyanide onto F186A-CPO in 25 mM phosphate buffer pH 5.90.
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Figure 4.9 Titration of cyanide onto F103A/F186A-CPO in 25 mM phosphate buffer
pH 5.90.
4.3.4

Catalytic Properties of WT-, F186A-, and F103A/F186A-CPO

The changes introduced in the substrate-binding pocket should influence the catalytic
properties of CPO as these residues interact with the incoming substrate and guarding their
access to the heme center. In this part of my study, the pH profile of halogenation,
peroxidation, epoxidation, and dismutation activities of the CPO mutants were tested and
compared to that of WT-CPO.
4.3.4.1 Halogenation Activity of WT-, F186A-, and F103A/F186A-CPO
Chlorination is the primary function of CPO and this activity defined the enzyme as
many haloperoxidases are incapable of catalyzing chlorinating reactions. The results of the
mutants were quite interesting as a small single mutation in the substrate-binding pocket
hindered the halogenation activity. In Figure 4.10, the optimum pH for chlorination
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catalyzed by WT-CPO is at 2.75 and the activity decreases significantly as the pH risen.
However, F186A- and F103A/F186A-CPO shown no significant sign of chlorinating
activity at the tested pH range. Similar results were observed for the bromination assay
(Figure 4.11). The mutation in the substrate-binding pocket might possibly induced a slight,
as there is no significant difference in the secondary structure, change in the halide-binding
sites or induced a disruption of the proximity hydrogen bond between His105 and Glu183,
which resulted in the demolition of CPO’s halogenating activity. An alternate explanation
is the mutation caused a decrease in the redox potential of Compound I where the oxidation
of the halide ions is not permitted.

Figure 4.10 Specific activity of WT-, F186A- and F103A/F186A-CPO for chlorination
of MCD assay at pH 2.00-6.00. (Some error bars are not visible on the graph).
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Figure 4.11 Specific activity of WT-, F186A- and F103A/F186A-CPO for bromination
of MCD assay at pH 2.00-6.00. (Some error bars are not visible on the graph).
4.3.4.2 Peroxidation Activity of WT-, F186A-, and F103A/F186A-CPO
As a heme peroxidase, CPO can catalyze one electron oxidation of substrates yielding
a radical product. In the case of ABTS assay, the substrate, ABTS, is oxidized in two one
electron transfer process to ABTS2+. WT-CPO has an optimum pH of 2.50 for catalyzing
peroxidation reaction and the activity is significantly reduced at pH 4.00 or above (Figure
4.12). As for F186A- and F103A/F186A-CPO, the optimum pH is at 3.00 while the activity
remained active at pH 4.00-5.00 but the activity is negligible at pH 6.00.
As observed in Figure 4.13, the comparison between WT-CPO and the CPO mutants
at pH 2.50 and 4.00 clearly demonstrated their difference. At pH 2.50, F186A- and
F103A/F186A-CPO possess about 30% activity relative to WT-CPO. However, the
peroxidation activity of F186A- and F103A/F186A-CPO was enhanced by more than 8-
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folds relative to WT-CPO at pH 4.00. A plausible explanation for the difference in activity
is the pKa of Compound II for the CPO mutants is greater than that of WT-CPO. The
peroxidation pathway of CPO involved a second intermediate, Compound II, and the active
state of this species was proposed to be the protonated form. Therefore, regulation of the
pKa of Compound II plays an important role in the peroxidation activity and this could be
the plausible explanation on the activity of the CPO mutants at higher pH.

Figure 4.12 Specific activity of WT-, F186A- and F103A/F186A-CPO for peroxidation
of ABTS assay at pH 2.50-6.00. (Some error bars are not visible on the graph).
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Figure 4.13 Relative activity of WT-, F186A- and F103A/F186A-CPO for
peroxidation of ABTS assay at pH 2.50 (Left) and 4.00 (Right). (Some error bars are
not visible on the graph).
4.3.4.3 Epoxidation and Dismutation Activity of WT-, F186A-, and F103A/F186ACPO
The epoxidation activity of WT-, F186A-, and F103A/F186A-CPO was evaluated at
pH 3.00-5.50. Within this pH range, WT-CPO and the mutants displayed a similar trend as
observed in Figure 4.14. Even though they shared a similar trend, the relative activity
differed. In Figure 4.15, the activity of F186A- and F103A/F186A-CPO is relatively 7- and
8-folds of WT-CPO at pH 4.50, respectively.
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Figure 4.14 Specific activity of WT-, F186A- and F103A/F186A-CPO for epoxidation
of styrene assay at pH 3.00-5.50. (Some error bars are not visible on the graph).

Figure 4.15 Relative activity of WT-, F186A- and F103A/F186A-CPO for epoxidation
of styrene assay at pH 4.50.
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This significant enhancement might be at the expense of the dismutation pathway as
they have a competing relationship. In Figure 4.16, the catalatic activity of F186A- and
F103A/F186A-CPO was significantly less than that of WT-CPO at the pH profile of 2.506.00. The decrease in the catalatic activity of CPO allowed more oxidants to be utilized in
catalyzing the epoxidation of styrene as enhancement was observed for the mutants. As
proposed in the previous sections, the plausible reduction on the redox potential of the CPO
mutants’ Compound I might be the cause on the changes in the dismutation activity, as the
oxidation of hydrogen peroxide is prohibited.

Figure 4.16 Specific activity of WT-, F186A-, and F103A/F186A-CPO for dismutation
of hydrogen peroxide assay at pH 2.50-6.00. (Some error bars are not visible on the
graph).
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4.3.5

Epoxidation of Styrene and its derivatives catalyzed by WT-, F186A-, and
F103A/F186A-CPO

CPO catalyzes the epoxidation of styrene and its derivatives yielding epoxides in (R)and (S)-configurations. These enantiomers were proven to be successfully separated and
identified by Whelk-O 1 column of HPLC. It has been previously identified that Whelk-O
1 column can maintain the same elution order for similar enantiomers [139]. The elution
order of the column tends to be the (R)-enantiomer then followed by the (S)-enantiomer as
the retention time of the (R)-configuration is shorter than that of the (S)-configuration in
Whelk-O 1 column. This elution order of the enantiomers was confirmed previously in our
lab through the (R)- and (S)-styrene oxide standards [140].
4.3.5.1 Epoxidation of Styrene
Th products of the styrene epoxidation catalyzed by WT-, F186A-, and F103A/F186ACPO were extracted and analyzed by HPLC. As observed in Figure 4.17, 4.18, and 4.19,
WT-CPO and the CPO mutants yielded two products, (R)- and (S)-styrene oxide. The
resolution factor, Rs, of WT-, F186A-, and F103A/F186A-CPO were 2.27, 1.67, and 1.82,
respectively. The retention factors, k1’ and k2’, for WT-CPO were 6.04 and 7.71,
respectively. As for the mutants, F186A-CPO’s retention factors were 6.12 and 7.78 and
F103A/F186A-CPO’s retention factors were 6.42 and 8.17. The separation factors, α, of
WT-, F186A-, and F103A/F186A-CPO were fairly similar as they were 1.28, 1.27, and
1.27, respectively.

101

Figure 4.17 Enantioseparation of styrene oxide catalyzed by WT-CPO on Whelk-O 1
column at room temperature with pure hexane as mobile phase while the absorbance
is monitored at 215.7 nm.

Figure 4.18 Enantioseparation of styrene oxide catalyzed by F186A-CPO on WhelkO 1 column at room temperature with pure hexane as mobile phase while the
absorbance is monitored at 215.7 nm.
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Figure 4.19 Enantioseparation of styrene oxide catalyzed by F103A/F186A-CPO on
Whelk-O 1 column at room temperature with pure hexane as mobile phase while the
absorbance is monitored at 215.7 nm.
The epoxidation of styrene catalyzed by WT-CPO yielded (R)-styrene oxide as major
product with an enantiomeric excess of 44%. As for F186A- and F103A/F186A-CPO, the
ee value was 3 % and 9%, respectively. The significant decrease on the ee value for the
mutants suggested that the original interactions between styrene and Phe103/Phe186 were
disrupted. The larger substrate-binding pocket in the mutants allowed styrene to bind in
more conformations thus lead to the decrease on the enantioselectivity.
4.3.5.2 Epoxidation of cis-β-methylstyrene
CPO catalyzes the epoxidation of cis-β-methylstyrene yielding only (1S, 2R)-cis-βmethylstyrene oxide as observed in Figure 4.20. However, F186A- and F103A/F186ACPO yielded two products, one has been previously identified as the (1S, 2R)-enantiomer
(Figure 4.21 and 4.22). The separation factor for the two mutants was the same, 1.06. As
for the retention factors, F186A-CPO were 5.79 and 6.12 while F103A/F186A-CPO were
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6.02 and 6.38. The calculated Rs for F186A- and F103A/F186A-CPO was 0.78 and 0.73,
respectively. The reaction catalyzed by F186A-CPO yielded an ee value of 42% while
F103A/F186A-CPO only yielded an ee value 12%. The mutations on Phe103 and Phe186
disturbed the Phe103/Phe186 clamp and their interactions with the substrate, which result
in the significant loss on the enantioselectivity for cis-β-methylstyrene. The
enantioselectivity decreased more significantly as the size of the substrate-binding pocket
increased.
4.3.5.3 Epoxidation of trans-β-methylstyrene
The epoxidation of trans-β-methylstyrene catalyzed by WT-CPO and the mutants
yielded (1R, 2R)-enantiomer and (1S, 2S)-enantiomer in the same elution order as
illustrated in the Figure 4.23, 4.24 and 4.25. The presence of a third peak in the spectrum
could be the further oxidized or hydrolyzed product of the reaction. The calculated
resolution factors were 3.90, 4.09, and 4.96 for WT-, F186A-, and F103A/F186A-CPO,
respectively. The retention factors, k1’ and k2’, for WT-CPO were 7.70 and 12.10. As for
the mutants, F186A-CPO’s retention factors were 7.92 and 12.52 and F103A/F186ACPO’s retention factors were 7.75 and 12.37. The ee values for WT-CPO was only 8%
while F186A-CPO was 19%. The double mutant, F103A/F186A-CPO, has an ee value of
55%. Since the interactions between WT-CPO and trans-β-methylstyrene restricted the
access to the heme center, the presence of a larger substrate-binding pocket in the CPO
mutants can better accommodate the substrate, thus enhanced the yield and
enantioselectivity for this reaction.
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Figure 4.20 Enantioseparation of cis-β-methylstyrene oxide catalyzed by WT-CPO on
Whelk-O 1 column at room temperature with pure hexane as mobile phase while the
absorbance is monitored at 215.7 nm.

Figure 4.21 Enantioseparation of cis-β-methylstyrene oxide catalyzed by F186A-CPO
on Whelk-O 1 column at room temperature with pure hexane as mobile phase while
the absorbance is monitored at 215.7 nm.
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Figure 4.22 Enantioseparation of cis-β-methylstyrene oxide catalyzed by
F103AF186A-CPO on Whelk-O 1 column at room temperature with pure hexane as
mobile phase while the absorbance is monitored at 215.7 nm.
.

Figure 4.23 Enantioseparation of trans-β-methylstyrene oxide catalyzed by WT-CPO
on Whelk-O 1 column at room temperature with pure hexane as mobile phase while
the absorbance is monitored at 215.7 nm.
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Figure 4.24 Enantioseparation of trans-β-methylstyrene oxide catalyzed by F186ACPO on Whelk-O 1 column at room temperature with pure hexane as mobile phase
while the absorbance is monitored at 215.7 nm.

Figure 4.25 Enantioseparation of trans-β-methylstyrene oxide catalyzed by
F103A/F186A-CPO on Whelk-O 1 column at room temperature with pure hexane as
mobile phase while the absorbance is monitored at 215.7 nm.
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4.3.5.4 Epoxidation of trans-β-ethylstyrene
In the epoxidation reaction of trans-β-ethylstyrene, WT- CPO and the CPO mutants
yielded two products, the (1R, 2R)-enantiomer and the (1S, 2S)-enantiomer, as observed in
Figure 4.26, 4.27, and 4.28. The retention factors were 5.52 and 8.12 for WT-CPO, 5.78
and 8.39 for F186A-CPO, and 5.96 and 8.61 for F103A/F186A-CPO. The separation
factors of these products were 1.47, 1.45, and 1.44 for WT-, F186A-, and F103A/F186ACPO, respectively. In comparison of the ee values, the CPO mutant displayed improvement
to the enantioselectivity of the reaction as the ee value for WT-, F186A-, and
F103A/F186A-CPO were 3%, 23%, and 21%, respectively. Interestingly, the epoxidation
of trans-β-ethylstyrene catalyzed by the two mutants favors the yield of the (1S, 2S)enantiomer.

Figure 4.26 Enantioseparation of trans-β-ethylstyrene oxide catalyzed by WT-CPO
on Whelk-O 1 column at room temperature with pure hexane as mobile phase while
the absorbance is monitored at 218.0 nm.
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Figure 4.27 Enantioseparation of trans-β-ethylstyrene oxide catalyzed by F186A-CPO
on Whelk-O 1 column at room temperature with pure hexane as mobile phase while
the absorbance is monitored at 218.0 nm.

Figure 4.28 Enantioseparation of trans-β-ethylstyrene oxide catalyzed by
F103A/F186A-CPO on Whelk-O 1 column at room temperature with pure hexane as
mobile phase while the absorbance is monitored at 218.0 nm.
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4.3.5.5 Epoxidation of trans-β-propylstyrene
The epoxidation of trans-β-propylstyrene catalyzed by WT-CPO and the mutants
yielded (R)-enantiomer and (S)-enantiomer in the same elution order. In Figure 4.29, 4.30,
and 4.31, the separation factors were calculated to be 1.45, 1.45, and 1.47 for WT-, F186A-,
and F103A/F186A-CPO, respectively. The retention factors, k1’ and k2’, for WT-CPO were
6.70 and 9.73. As for the mutants, F186A-CPO’s retention factors were 6.36 and 9.24 and
F103A/F186A-CPO’s retention factors were 5.76 and 8.44. As for the resolution factor,
WT-, F186A-, and F103A/F186A-CPO were 3.16, 3.34, and 2.73, respectively. The ee
values for the reaction catalyzed by WT-CPO was 11% while F186A-CPO was 10%. The
double mutant, F103A/F186A-CPO, has an ee value of 14%. The minor difference between
WT-, F186A-, and F103A/F186A-CPO clearly indicated that they have similar
enantioselectivity for trans-β-propylstyrene.

Figure 4.29 Enantioseparation of trans-β-propylstyrene oxide catalyzed by WT-CPO
on Whelk-O 1 column at room temperature with pure hexane as mobile phase while
the absorbance is monitored at 218.0 nm.
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Figure 4.30 Enantioseparation of trans-β-propylstyrene oxide catalyzed by F186ACPO on Whelk-O 1 column at room temperature with pure hexane as mobile phase
while the absorbance is monitored at 218.0 nm.

Figure 4.31 Enantioseparation of trans-β-propylstyrene oxide catalyzed by
F103A/F186A-CPO on Whelk-O 1 column at room temperature with pure hexane as
mobile phase while the absorbance is monitored at 218.0 nm.
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4.4 Conclusion
The substrate-binding pocket of CPO was proposed to interact with the incoming
substrates and restricting their access to the ferryl oxygen of the catalytic heme center.
These interactions play an important role in regulating the enantioselectivity of the oxygeninsertion reactions. The bottom of the substrate-binding pocket of CPO was formed by the
side chains of Phe103, Val182, and Phe186. These side chains along with those of Leu70
and Ala267 have been shown in docking study to have hydrophobic interaction with
dimethylaniline, where CPO can catalyze the oxidative demethylation of the substrate
[141].
In the present study, Phe186 was mutated to an alanine residue through site-directed
mutagenesis generating the F186A-CPO mutant as well as the double, F103A/F186ACPO, mutant. The characterization of F186A- and F103A/F186A-CPO revealed that these
two mutants were quite different than WT-CPO. For instance, the UV-Vis spectra of the
two mutants indicated the presence of a low-spin hexa-coordinated species while the
spectrum of WT-CPO clearly revealed the heme iron is penta-coordinated. Even though
the mutations altered the spin nature, from high-spin to low-spin, of the resting enzyme,
the identity of the proximal ligand remained the same. The carbonmonoxy complexes of
WT-, F186A-, and F103A/F186A-CPO possess the signature Soret peak at 445 nm as an
indication of a thiolate ligation. The CD spectrum of F186A- and F103A/F186A-CPO was
similar to that of WT-CPO as no significant difference was observed for their secondary
structure. Further spectroscopic study of these two mutants suggested that these mutations
altered the binding affinity of exogenous ligands, such as cyanide, to the heme center of
CPO.
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Besides the spectroscopic characterization of the mutants, the influence on the
biochemical properties of CPO was also characterized. Interestingly, the single mutation
of Phe186 to alanine caused dramatic changes on the catalytic activity of CPO. F186ACPO contains no significant sign of halogenation, chlorination and bromination, activity
relative to WT-CPO. Similar results were observed for F103A/F186A-CPO. The change
in the halogenating activity observed for F186A- and F103A/F186A-CPO suggested the
possible decrease on the redox potential of Compound I, where the oxidation of halide ions
is inefficient. This hypothesis is further supported by the abolishment of the catalatic
activity of F186A-CPO, where the oxidation of hydrogen peroxide by Compound I is also
prohibited. Another plausible reasoning was the mutation influenced the catalytic heme
center rendering the reaction with polar substrates, such as chloride ion and hydrogen
peroxide, unfavorable. The peroxidase activity of F186A- and F103A/F186A-CPO was
increased by more than 8-fold at pH 4.00 and 5.00 relative to WT-CPO. This can be
explained by the inverse relationship between redox potential of the heme center and the
pKa of the distal ligand. Therefore, the decrease in the redox potential would regulate the
increase in the pKa of F186A- and F103A/F186A-CPO’s Compound II, favoring the
formation of the protonated species. Besides the peroxidation pathway, the oxygeninsertion pathway was also enhanced for the CPO mutants. Throughout the tested pH range
3.00-5.50, F186A- and F103A/F186A-CPO displayed a minimum of 5-fold enhancement
relative to WT-CPO. The biochemical properties of F186A- and F103A/F186A-CPO seem
to be a better applicable biocatalyst than WT-CPO.
To further investigate the possible application of the CPO mutants, the
enantioselectivity of F186A- and F103A/F186A-CPO catalyzed epoxidation reactions of
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styrene, cis-β-methylstyrene, trans-β-methylstyrene, trans-β-ethylstyrene, and trans-βpropylstyrene were examined with HPLC Whelk-O 1 column. As expected, F186A- and
F103A/F186A-CPO displayed different epoxidation behavior relative to WT-CPO. For
example, the reaction catalyzed by WT-, F186A-, F103A/F186A-CPO of styrene
epoxidation yielded different ee values. As F186A-CPO, the ee value is 3.5% which
decreased by more than 30% as to the WT-CPO catalyzed styrene epoxidation reaction.
The change in the ee values might arise from the mutations on the Phe103/Phe186 clamp,
where the presence of a larger substrate-binding pocket disturbed the interactions between
styrene and the phenylalanine residues as well as the binding conformation of the substrate
during the binding process. This proposition was further supported by the epoxidation
reaction of trans-β-methylstyrene. Trans-β-methylstyrene is a poor substrate for WT-CPO
as the ee value is only 8%. However, F186A- and F103A/F186A-CPO displayed a higher
enantioselectivity for trans-β-methylstyrene as the ee value is 19% and 55%, respectively.
Interestingly, the epoxidation of trans-β-ethylstyrene catalyzed by the two mutants
displayed higher enantioselectivity for this substrate but the conformation preference is
different, with the (S)-enantiomer as the major product. As for trans-β-propylstyrene, the
enantioselectivity for this reaction catalyzed by WT-, F186A-, and F103A/F186A-CPO has
no significant difference.
WT-CPO catalyzes epoxidation of cis-β-methylstyrene with high enantioselectivity,
suggesting the proper fit of the substrate in the substrate-binding pocket. My result
confirms the high enantioselectivity of this reaction. As for the CPO mutants, the reaction
yielded two products indicating the decrease in the enantioselectivity for cis-βmethylstyrene. Since the interactions between WT-CPO and the substrate is disturbed by
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the mutation(s), the ee value decreased as the space in the substrate-binding pocket
increased. The enantioselective profile of F103A-, F186A-, and F103A/F186A-CPO
suggests Phe186 plays a role in modulating the enantioselectivity of as illustrate in Table
4.5.
Table 4.5 Enantioselectivity (ee%) comparison between WT-, F103A-, F186A-, and
F103A/F186A-CPO.
Proteins

Styrene

Cis-βTrans-βTrans-βmethylstyrene methylstyrene ethylstyrene

WT-CPO

44%

~99%

8%

3%

F103A-CPO [124]

2%

5%

50%

34%

F186A-CPO

3%

42%

19%

23% (S)

F103A/F186A-CPO

9%

12%

55%

21% (S)

Mutation on Phe186 favors the yield of the (S)-enantiomer on the epoxidation of transβ-ethylstyrene but this preference was no observed for F103A-CPO. Phe103 plays a more
significant role relative to Phe186 as F103A-CPO displayed a higher enantioselectivity for
trans-substituent styrene derivative reactions. For example, F103A-CPO catalyzes the
epoxidation of trans-β-methylstyrene and trans-β-ethylstyrene with the ee values of 51%
and 48%, respectively [124]. The different degree of influence between Phe103 and
Phe186 might possibly be due to the flexibility of Phe103, as the crystal structure indicates
the displacement of Phe103 during the binding of CPD, while Phe186 remained intact [70].
Furthermore, a computational study on the distal pocket of CPO’s influence on the
epoxidation of cis-β-methylstyrene provided us an insight on the flexibility of Phe103 and
Phe186 that during the breathing of the distal pocket, Phe103 is displaced more
significantly than Phe186 [142].
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My work further the understanding on the influence of the distal pocket of CPO toward
the catalytic properties as well as the enantioselective profile of the enzyme. Furthermore,
these results added on the possible industrial applications of CPO, as well as other hemethiolate enzymes and through protein engineering, certain aspect of the structure can be
modified to favor certain reactions such as enantioselective peroxygenation reactions.
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APPENDIX
Figure A1. DNA sequence of full-length WT CPO gene.
ATGTTCTCCAAGGTCCTTCCCTTCGTGGGAGCGGTTGCCGCCCTCCCTCACTC
CGTCCGTCAGGAGCCTGGCTCCGGCATTGGCTACCCATACGACAACAACACC
CTGCCATATGTCGCCCCAGGTCCTACCGACTCTCGTGCTCCTTGCCCAGCTCT
GAACGCTCTTGCCAACCACGGTTACATTCCTCACGATGGCCGTGCCATCAGC
AGGGAGACCCTCCAGAACGCTTTCCTCAACCACATGGGTATTGCCAACTCCG
TCATTGAGCTTGCTCTGACCAACGCCTTCGTCGTCTGCGAGTACGTTACTGGC
TCCGACTGTGGTGACAGCCTTGTCAACCTGACTCTGCTCGCCGAGCCCCACGC
TTTCGAGCACGACCACTCCTTCTCCCGCAAGGATTACAAGCAGGGTGTCGCC
AACTCCAACGACTTCATCGACAACAGGAACTTCGATGCCGAGACCTTCCAGA
CCTCTCTGGATGTCGTTGCAGGCAAGACCCACTTCGACTATGCCGACATGAA
CGAGATCCGCCTTCAGCGCGAGTCCCTCTCCAACGAGCTTGACTTCCCCGGTT
GGTTCACCGAGTCCAAGCCAATCCAGAACGTCGAGTCTGGCTTCATCTTCGCC
CTTGTCTCTGACTTCAACCTGCCCGACAACGATGAGAACCCTCTGGTTCGCAT
TGACTGGTGGAAGTACTGGTTCACCAACGAGTCCTTCCCATACCACCTCGGCT
GGCACCCCCCGTCTCCAGCCAGGGAGATCGAGTTCGTCACCTCCGCCTCCTCC
GCTGTCCTGGCTGCCTCTGTCACCTCTACTCCATCTTCCCTTCCATCCGGTGCC
ATCGGCCCAGGTGCCGAGGCTGTCCCTCTCTCCTTCGCCTCCACCATGACCCC
ATTCCTCCTCGCCACCAATGCTCCTTACTACGCCCAGGACCCAACTCTCGGCC
CCAACGACAAGCGTGAGGCTGCCCCAGCTGCCACCACCTCCATGGCCGTCTT
CAAGAACCCATACCTCGAGGCCATTGGCACCCAGGACATCAAGAACCAGCA
GGCTTACGTCAGCTCCAAGGCTGCTGCCATGGCCTCTGCCATGGCCGCCAAC
AAGGCCCGCAACCTTTAA
Figure A2. Amino acid sequence of WT-CPO.
XEPGSGIGYPYDNNTLPYVAPGPTDSRAPCPALNALANHGYIPHDGRAISRETLQ
NAFLNHMGIANSVIELALTNAFVVCEYVTGSDCGDSLVNLTLLAEPHAFEHDHSF
SRKDYKQGVANSNDFIDNRNFDAETFQTSLDVVAGKTHFDYADMNEIRLQRESL
SNELDFPGWFTESKPIQNVESGFIFALVSDFNLPDNDENPLVRIDWWKYWFTNES
FPYHLGWHPPSPAREIEFVTSASSAVLAASVTSTPSSLPSGAIGPGAEAVPLSFAST
MTPFLLATNAPYYAQDPTLGPND
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